The Peter Attia Drive - September 12, 2022


#222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D


Episode Stats

Length

2 hours and 27 minutes

Words per Minute

190.7539

Word Count

28,161

Sentence Count

1,660

Hate Speech Sentences

5


Summary

In this episode, Dr. Matt Caberlin joins me in person to talk about nutrition and aging. We discuss his recent review article on caloric restriction, epigenetic clocks, and the role of proteins and enzymes in aging, and how they affect DNA and cell reprogramming.


Transcript

00:00:00.000 Hey, everyone. Welcome to The Drive Podcast. I'm your host, Peter Atiyah. This podcast,
00:00:15.480 my website, and my weekly newsletter all focus on the goal of translating the science of
00:00:19.380 longevity into something accessible for everyone. Our goal is to provide the best content in
00:00:24.360 health and wellness, full stop, and we've assembled a great team of analysts to make
00:00:28.420 this happen. If you enjoy this podcast, we've created a membership program that brings you
00:00:32.680 far more in-depth content. If you want to take your knowledge of the space to the next level,
00:00:36.980 at the end of this episode, I'll explain what those benefits are. Or if you want to learn more now,
00:00:41.960 head over to peteratiyahmd.com forward slash subscribe. Now, without further delay,
00:00:47.760 here's today's episode. My guest this week is Matt Caberlin, who of course is a returning guest.
00:00:54.940 He's been a previous podcast guest a number of times, most recently joining me on AMA 35 back
00:00:59.980 in May of 2022. Matt is not only one of our most recurring guests, but he's also one of the people
00:01:05.100 I will consistently share emails with discussing various topics. Probably not a week goes by that
00:01:09.680 we're not sending each other a paper or something like that. And so when I found out when Matt was
00:01:13.580 going to be in Texas for a project, I figured let's sit down together in person and do one of
00:01:18.780 these things instead of remotely, which we normally do. In this episode, we really focus the conversation
00:01:23.460 around nutrition as it relates to aging and longevity. This really came out of a paper that
00:01:29.120 Matt wrote as a review article about a year ago, which I remember reading in draft, really appreciating
00:01:34.200 it and loved reading the final version of it. So even though nutrition science is not the topic I'm
00:01:39.640 most interested in talking about, given things I've mentioned in the past, which is sort of diets and
00:01:44.500 fads and the religion around that stuff, we tried to really make this as biochemical a discussion as
00:01:50.720 possible. So we obviously discuss Matt's recent review article, and we talk pretty deeply about
00:01:56.100 the literature on caloric restriction. We talk about epigenetic clocks, aging, and its effect on
00:02:00.960 DNA and cell reprogramming. We then focus around protein and aging. So this is the one macronutrient
00:02:07.660 that stands out, right? Carbohydrates and fats are really there for energy use. Protein is not.
00:02:13.620 We then get into this seeming dichotomy around protein and mTOR. You've obviously heard me talk a lot
00:02:19.020 about mTOR. We understand that a drug that inhibits mTOR, namely rapamycin, seems to produce a whole
00:02:25.700 bunch of wonderful effects. And yet protein, particularly an amino acid called leucine,
00:02:30.440 seem to really trigger mTOR. So how can those two things simultaneously be true if having muscle is
00:02:36.500 good, but taking rapamycin is probably good? We get into the importance of muscle mass, the RDA on
00:02:42.100 protein itself, IGF, growth hormone, and a lot more. I want to point something out here. This is a topic
00:02:48.280 for which we just don't have easy answers. And it's possible you're going to walk away from this
00:02:53.440 entire conversation with more questions than answers. My goal is that you come away from this
00:02:58.420 realizing that, yeah, there's quite a bit of uncertainty here, but I have a better way that
00:03:01.720 I can think about it. And I have a better sense of what questions to ask. Now, for those of you who
00:03:05.840 may not remember who Matt is, or maybe even didn't listen to any of our previous podcasts, let me just
00:03:10.300 give you a really brief reminder. Matt is a globally recognized leader in the basic biology of aging.
00:03:15.800 He's a professor of laboratory medicine and pathology and adjunct professor of genomic
00:03:20.560 sciences and an adjunct professor of oral health sciences at the University of Washington in
00:03:24.120 Seattle. His research interests are focused on the basic mechanisms of aging in order to facilitate
00:03:28.320 translational interventions that promote healthspan and promote a healthy way of life.
00:03:32.160 So without further delay, please enjoy my conversation with Matt Cable.
00:03:40.320 Matt, it's great to finally be able to do one of these in person with you. We've done a lot of
00:03:44.060 these remotely. We're taking advantage of the fact that you're in Texas filming a documentary about
00:03:48.540 aging, which is pretty awesome. So when we knew that this was going to happen, we said, well,
00:03:52.580 let's take advantage of you being here and let's come up with something that we both talk about so
00:03:56.720 much over email, which is to say, I don't think a week goes by that we aren't exchanging an email
00:04:02.160 about some aspect of the relationship or the inner space between nutrition and longevity.
00:04:07.900 Does that speak to our ignorance? Does that speak to the ubiquity of such content? I don't know.
00:04:11.920 What does that say about us? It's an area that a lot of people are
00:04:14.640 really interested in and it certainly intersects with popular culture. So having been in the aging
00:04:20.540 field for a long time, I certainly recognize how complicated that biology is. And I think the biology
00:04:26.380 of nutrition is equally complicated. And when you get at the interface of those two, it's really hard,
00:04:33.200 I think, sometimes to draw a definitive conclusion. So a new paper will come out and you usually read the
00:04:38.160 papers before I do and you're like, hey, what do you think about this? And then, you know,
00:04:41.660 we throw it back and forth. It's hard sometimes to get to concrete answers. So certainly we'll try to
00:04:46.540 do that today. But I also think this will be a little bit of a theme that there are many things we
00:04:50.980 don't understand yet about optimal nutrition and how that intersects with optimal health span.
00:04:56.880 You and I have spent so much time on the podcast speaking about the molecules. Of course,
00:05:02.100 our favorite being rapamycin, but all sorts of them, right? We recently talked about NMNNR,
00:05:06.020 NAD. We've talked about metformin. And it's easier almost to ask the questions from the standpoint of
00:05:12.700 gyroprotective molecules because the intervention is much cleaner.
00:05:15.520 Yeah, absolutely.
00:05:16.360 Like, are you taking this drug? Yes or no? And of course, what's interesting about that,
00:05:20.940 and I think it speaks to what we're going to talk about today, think about the one drug among those
00:05:26.420 that stands out, which is rapamycin. Even within that, just I think yesterday or two days ago,
00:05:31.440 you and me and David Sabatini had a back and forth about timing of the dose, frequency within the
00:05:38.000 dosing schedule, the dose itself. I mean, even with a drug, it's still very complicated to say,
00:05:45.180 well, what about during this phase? Because the study I think we were talking about was looking
00:05:48.600 at mice and it was asking the question of early exposure of rapamycin later in life,
00:05:53.580 constant dosing, intermittent dosing. That's for a drug. And we're still struggling to piece it
00:05:58.520 together. Now imagine trying to ask that question of your food.
00:06:03.020 You know, we'll obviously talk a lot as well about the animal models and what they can tell us about
00:06:06.960 what might affect human aging. But the big piece that gets lost with the animal models on top of
00:06:11.860 all that complexity is the environment. You know, we keep these mice in a well-controlled environment,
00:06:17.180 usually relatively pathogen-free, and they live in that same environment their entire life.
00:06:22.460 Now you think about the human experience where our environment is extremely complicated. We're
00:06:26.600 constantly getting bombarded with all sorts of challenges and infectious agents. And our
00:06:32.240 environment changes dramatically throughout our lives. In fact, maybe this is something we want
00:06:37.200 to touch on. A lot of the epidemiological studies on optimal nutrition are from 20, 30, 40 years ago.
00:06:44.560 The average human environment is very different today than it was when those studies were done. And
00:06:49.140 how does that potentially change the interaction between nutrition and health outcomes? I think it's a
00:06:55.680 really interesting but challenging question to address to anybody's satisfaction, honestly.
00:07:01.820 Yeah, that's actually a great point. And I made a similar point on a totally different topic,
00:07:06.340 which was all of the studies that talk about cancer screening are very backwards-looking by definition,
00:07:12.520 right? You have to look at controlled trials that were done in the past. But the technology of
00:07:16.220 radiology is changing so much. Radiology is a very, you know, physics-based field of medicine.
00:07:21.640 And so when you read a study that talked about mammography for screening, you know,
00:07:26.580 it was a 15-year study, right? So it's a great study. Well, by definition, it was done based on 30
00:07:31.600 to 20-year-old technology that by the time the study has been completed, you have the follow-up data,
00:07:39.100 you write up the paper. It doesn't necessarily represent what's happening today. And that's a huge
00:07:44.340 challenge of evaluating that type of data.
00:07:46.000 And in people, because we age so slowly, there's really not a lot you can do about that if you want
00:07:52.900 to try to do correlative longitudinal studies of aging. Because people age so slowly, the people
00:07:59.200 who are in their 70s today were in their 30s 40 years ago. And so the environment that they were in
00:08:04.860 is probably quite different than the environment that 30-year-olds are in today. So there's not a
00:08:09.920 great way around that. I think the key is to recognize that limitation and be potentially
00:08:16.960 even more careful about assuming causation from correlation over many decades.
00:08:23.540 There's a bit of a mea culpa on the topic of nutrition, which is really my least favorite
00:08:27.840 topic, despite the fact that it keeps coming up on this podcast and it's unavoidable.
00:08:31.940 As I reflect back on my own understanding of this topic, the strength with which I held
00:08:38.740 convictions over the past more than decade, I would say I've gone in reverse, right? I have
00:08:44.740 looser and looser convictions as time goes on. And I view fewer and fewer things with certainty as time
00:08:51.160 goes on. When I think about this problem clinically, I have what I would consider to be an incredibly
00:08:57.620 simple framework, which is if I'm looking at a patient, I'm asking a question, are you over
00:09:02.520 nourished or under nourished? Are you under muscled or adequately muscled? So that's a two by two. And
00:09:09.680 then are you metabolically healthy or not? That's sort of my first order question. Now, one of those
00:09:15.880 spaces doesn't really have too many people in it. The adequately muscled, under nourished,
00:09:24.120 metabolically unhealthy bucket doesn't really exist. So these aren't people aren't uniform
00:09:27.600 distributed in those buckets, but it's a pretty good way to sort people. And you can't sort someone
00:09:34.480 by looking at them into that bucket, but by looking at them, doing some functional testing,
00:09:39.260 looking at their biomarkers, and that might include also doing things like a DEXA scan where you can
00:09:43.900 actually get some objective data. You can pretty quickly figure that out. And the reason we think
00:09:48.440 that's important is it helps us understand, do you need an energy deficit? Do you need an energy
00:09:54.920 surplus? What's your protein intake need to be to achieve that in combination with your calorie
00:10:00.980 needs? And the hardest of those to treat by far is over nutrition, under muscled. And unfortunately,
00:10:10.600 that's a very common phenotype. That's a lot of people these days. Yeah. I think as a general
00:10:14.900 approach, first order approach, that makes a ton of sense. You know, one of the things that that
00:10:19.620 allows you to recognize, right, is that the optimal strategy isn't, there's no one size fits all,
00:10:25.300 I guess would be the way I'd say it. Different people are going to have different needs nutritionally
00:10:30.100 and what works really well for one person may not work at all for another person. And so I think
00:10:34.600 looking at that level allows you to not have to try to say everybody should be doing X. That is pretty
00:10:42.380 similar to the way I think about it. Obviously, I don't practice medicine and I try not to make
00:10:46.800 recommendations for what people should do. But in my own life, that's generally the way that I
00:10:51.160 try to approach it as well. And I hope I'm doing okay. You haven't tested me yet. So you can't tell
00:10:56.440 me which bucket I'm in. But I think I'm doing okay for my age with my nutritional strategies. And the
00:11:01.360 other thing that I sort of have realized similar to what you were saying before is that, you know,
00:11:05.340 it's an ongoing learning process. And so I think it's really important that we be willing to
00:11:09.880 change our beliefs about nutrition and other aspects of health as more data comes in. So I
00:11:18.020 think if you take that strategy, then you can be open to the possibility that what you believed
00:11:22.820 10 years ago might not have been exactly right. And maybe we need to tweak it a little bit.
00:11:27.700 I'll be honest, I have real trust problems with nutritionists. You know, in part, it stems from I
00:11:31.780 remember very vividly when I was, I think it was probably in my early 20s, I read one of these diet
00:11:37.100 guru books. This was, I'm going to date myself, but this was, you know, early 90s, I guess.
00:11:42.940 The theme back then was, you could eat anything you wanted, as long as you cut out the fat,
00:11:47.480 you could have this really high, simple carbohydrate diet, just keep it low fat, and you know,
00:11:52.600 you'll be fine. And we now know that's exactly wrong. I can't help but look at a lot of what people,
00:11:58.920 what I would put sort of on the fad diet side, the diet gurus, what they're saying today,
00:12:03.660 how do we know 10 years from now, we're not going to look back on that. And again,
00:12:07.560 be like, that just makes no sense. I think some of us today can look at some of what's out there and
00:12:11.840 say, that just makes no sense. But again, this gets back to what I was saying before. It's not
00:12:16.500 that I would say nutrition science is across the board, low quality. I think they're actually really
00:12:21.680 good scientists doing really good work in this area. It's just a really hard problem. And I do think
00:12:27.000 to some extent, the biology of aging, and the biology of nutrition do share that these are extremely
00:12:32.580 complicated biological systems, we're trying to understand in the context of this changing
00:12:40.080 environment over time. So I don't blame the scientists, I just think we have to be really
00:12:44.660 careful to recognize what the limitations are, and not draw really strong conclusions like,
00:12:51.460 everybody should eat, you know, a low protein diet. That's kind of one of the fads that are out
00:12:56.220 there today. That's a mistake to recommend across the board, nutritional strategies for everyone.
00:13:01.720 I guess the last thing, sorry, I'm talking a long time here. But I guess the last thing that what
00:13:05.380 you said makes me think of as well, and I think this is really important, because people lose sight
00:13:09.400 of this is exactly what you said, if you can be somewhere close to optimal nutritional intake,
00:13:16.700 just say total calories, regardless of composition, body composition is somewhere close to where it
00:13:22.340 should be. That's a big chunk of what you need to give yourself the best chance of being healthy
00:13:28.140 going forward. You don't have to optimize every single thing. And I know you're all into
00:13:33.240 optimization. And I respect that about you. I think if you can do that, that's great. But you
00:13:37.100 don't have to to get most of the benefits. And so I think starting from that big picture perspective
00:13:41.220 allows you to get most people most of the way there. And then when they're most of the way there,
00:13:47.200 you can focus on how do we get that last 10, 20, 30%, whatever it is.
00:13:51.700 I couldn't agree with you more, Matt. And I would argue, and I do argue now in a very different way
00:13:57.220 from where I used to be a few years ago. There are most things in my life where I don't like the
00:14:02.560 80-20 principle. My good friend, Tim Ferriss, he's the king of this. He's the king of how can I get 80%
00:14:09.360 of the learning with 20% of the time? And I've never seen anybody who can do it like Tim. Like the guy
00:14:15.820 can learn a language in a month. He can be 80% proficient in a language in a month. I'm the
00:14:21.760 opposite. I'm the guy who loves the tail. I love the asymptote. I love the perfection of something.
00:14:28.820 I would say in nutrition, that is exactly not where my interest lies. I agree that you can just get 80%
00:14:36.360 of this right by focusing on exactly what we've talked about. And the details, the complete
00:14:42.340 optimization are not worth it. And it's instead better to put that effort into exercise. That's
00:14:49.980 where I think if you're going to really go down the rabbit hole and put more of your mental energy,
00:14:55.440 more of your time, and more of your focus into something, you have far more of an ROI on the
00:15:00.900 exercise front than eking out incremental value on the nutrition front. I've joked about this before.
00:15:07.140 Other guests on the podcast, Lane Norton and I have had riffs on this back and forth.
00:15:10.200 The people who sit there on Twitter, which I realize is not a representative sampling of the
00:15:16.180 world. It's simply an annoying vocal group of people who will waste endless hours debating the
00:15:23.480 finer points of their dietary pet peeves who can't do 10 pull-ups is amazing. There should be a rule
00:15:30.440 that says if you can't deadlift twice your body weight and do 15 pull-ups, you shouldn't be allowed
00:15:36.700 to pontificate endlessly about the finer points of nutrition.
00:15:40.980 We can talk to Elon about that. Maybe that can be a new rule.
00:15:45.620 I think we've established nutrition matters here. But I think at the same time,
00:15:50.320 David Allison said it once to me, it's amazing how little we know about this subject matter.
00:15:55.020 Kind of rehashing what we've said. We know that too much and too little are bad. And for most of our
00:16:00.740 existence, we were worried about the too little problem. The too much problem has become a
00:16:05.780 relatively recent phenomenon. And they're bad in different ways. Acutely, chronically, they have
00:16:10.280 different limitations. We know that certain things are toxic, acutely or chronically. Not a lot we
00:16:16.800 know. I mean, with definitive clarity, there's not a lot we know beyond those things. One thing that
00:16:23.140 seems to be true is, at least from the animal literature, caloric restriction seems to reproducibly
00:16:32.040 improve lifespan. Let's kind of talk about how that came to be as an understanding.
00:16:37.100 This area of research is actually quite old.
00:16:40.060 It's like 100 years?
00:16:40.840 Yeah. The first experiments were published in the early to mid-1930s, which means they were probably
00:16:46.220 started in the 1920s. So almost 100 years ago, people were going down this line of thinking of
00:16:53.040 asking, you know, what is the effect of significant restriction of calories on the aging process in
00:17:00.160 mammals? So the early studies were all done in rats. If I remember correctly, these studies were
00:17:04.780 originally designed from a developmental perspective. So they were really thinking about
00:17:09.120 malnutrition and its effects on development. And as a byproduct, made the observation that yes,
00:17:15.720 when you restrict calories in a rat early on in life, they have a smaller body size. But then if you let
00:17:22.040 them live out their entire lives, this is in the laboratory, and I think that's really important
00:17:26.040 to keep in mind, they live 40%, 50% longer. So we're talking really significant increases in
00:17:32.860 lifespan. And then the other thing that was appreciated pretty quickly was, not only are
00:17:36.820 they living longer, but they seem to be healthier as they're living longer. So this concept of health
00:17:42.020 span and the period of life that is spent in good health, free from disease and disability,
00:17:47.120 it seemed as if caloric restriction was not only increasing lifespan, but also extending health
00:17:52.540 span. That led to a large body of literature since then, studying the effect of caloric restriction in
00:17:59.600 not just rodents, rats and mice, but also all sorts of simpler organisms, invertebrates like fruit
00:18:05.880 flies and C. elegans and yeast. And the common theme seems to be that, again, starting from laboratory
00:18:11.660 conditions, if you restrict nutrients by a whole variety of different methods, you can increase
00:18:18.720 lifespan and apparently increase health span proportionally, at least proportionally. So
00:18:24.160 there's a lot of nuance there, a lot that we can dive into and to unpack. But I think that's generally
00:18:28.540 the take-home, is that over and over and over again across the evolutionary distance we're talking
00:18:34.000 about is much, much greater than the evolutionary distance between rodents and humans. So over a very
00:18:40.400 wide evolutionary distance in pretty much every organism where it's ever been studied, you can
00:18:46.140 find evidence that caloric restriction slows aging. Again, there are cases where that didn't happen,
00:18:52.900 where lifespan wasn't extended, where lifespan was shortened. Maybe we want to talk about this at some
00:18:56.900 point. The interaction between genetics and environment and caloric restriction. But in general,
00:19:01.520 the take-home message is caloric restriction can slow aging in laboratory animals pretty much
00:19:07.460 everywhere where it's been studied. The one question that some people have is whether that's true in
00:19:12.300 non-human primates.
00:19:13.200 I was going to say, before we get to NIA Wisconsin, which is perhaps the single greatest experiment that's
00:19:19.840 ever been done to test this hypothesis, both in terms of its duration, level of control, and proximity
00:19:26.420 to our genome. Let's spend a moment on that. Before we do, any things that come up from the rodent
00:19:33.860 studies that are worth talking about? So for example, one of the things that I think is always
00:19:38.220 important to point out is there's a very particular death that tends to fall on laboratory mice. If you
00:19:44.660 look at the death bars for humans, there's much more heterogeneity, but the leading cause is
00:19:49.520 atherosclerosis. Now that's true in the United States. It's true across the globe. When you mix in
00:19:55.300 develop and undevelop, it doesn't matter. Laboratory mice aren't that way. They die of pretty much one
00:19:59.860 thing and one thing alone. And that is... Actually, it's euthanasia, but I know where you're
00:20:03.440 going. Cancer, right? So certainly every old mouse at time of death will have cancer. And again,
00:20:13.000 because of the way animal studies are done, usually you have defined endpoints where when a mouse
00:20:17.920 reaches that endpoint, they have to be euthanized. But the expectation is if they hadn't been euthanized,
00:20:22.760 they would have died from the cancer. So I think you're absolutely right.
00:20:24.820 They're not dying from atherosclerotic.
00:20:26.700 That's right. When you look at their arteries, they're not littered with plaques the way ours
00:20:30.600 are. At least the commonly used inbred mouse strains, that is definitely true for. There
00:20:35.820 are, this is maybe getting in the weeds a little bit, but there are certainly mouse strains that
00:20:39.820 have been designed either transgenically or through selection to develop other pathologies that will
00:20:45.460 shorten their lifespan. But if you let a typical mouse strain in the lab live out its natural life,
00:20:51.940 it will have a very high tumor burden at the end of life. And most likely, I guess I should know this.
00:20:57.780 I don't know exactly. I'm guessing 80% of the animals would die from cancer. So it's different
00:21:02.500 from humans in that way. And I actually think this is a legitimate criticism to some extent of the
00:21:07.320 caloric, the interpretation of the caloric restriction literature that is, could it be the
00:21:12.120 case that really what caloric restriction is doing is preventing cancer. And that's why you see these big
00:21:18.100 increases in lifespan. And I think that's really difficult to definitively answer one way or the
00:21:23.600 other. What I would say is mice do develop functional declines in every tissue and organ
00:21:30.280 as they age, very much like people do. So a person may die from cardiovascular disease,
00:21:35.520 but at the same time, if they're in their 80s, their kidney isn't functioning as well. Their heart
00:21:39.600 isn't functioning as well. Their brain probably isn't functioning as well. So mice show all of those
00:21:43.920 same declines in function with age and caloric restriction seems to delay or outright prevent
00:21:51.740 those declines as well. So yeah, maybe the lifespan effect is primarily due to cancer, but caloric
00:21:57.580 restriction is having an effect apparently on the underlying biological aging process in all sorts of
00:22:03.660 different ways. And I really like the functional measures. A lot of people in the field these days
00:22:07.760 are really enamored with the aging clocks, epigenetic clocks, biochemical markers. I think those are all
00:22:13.160 useful and important. But from my perspective, what really gets my attention is if somebody shows
00:22:18.300 that the heart is still functioning like a young heart or the immune system is still functioning.
00:22:22.040 Yeah. I wasn't planning to go down that rabbit hole, but since you brought it up,
00:22:25.280 can you convince me of the utility of the clocks absent the type of data that would actually demonstrate
00:22:32.240 longitudinally their benefit, which to my knowledge, we really don't have yet?
00:22:36.300 I would say a couple of things on that. I think we need to be precise in what we mean when we talk
00:22:41.040 about the clocks because there's lots of flavors of clocks. Most people these days, if you just say
00:22:45.820 aging clock, what they really mean are the epigenetic clocks that are showing the characteristic
00:22:50.540 changes in the epigenome, the epigenetic marks that are seen with age. Again, in every organism where
00:22:56.640 it's really been studied, you do see these characteristic changes in the epigenome with age.
00:23:01.660 And so I would say one place where their utility is clear, at least to me, is as a chronological
00:23:07.040 measure. Now you might ask, okay, why would I ever want to use an epigenetic clock to tell my
00:23:11.940 chronological age? I know how old I am, but forensics, for example, might be a place where
00:23:16.600 that's useful. Their crime has been committed. They want to know with some level of precision,
00:23:20.300 how old the perpetrator is. You could use an epigenetic clock for that reason. In my world,
00:23:25.260 as part of the dog aging project, there are many dogs that are rescued. An owner might want to know
00:23:29.880 their age. So I think that is a real use and clearly the clocks will work for that. I think really what
00:23:34.020 you're asking though is, can I convince you that the epigenetic clocks and potentially other types
00:23:39.240 of clocks are actually measuring biological aging? And that's a harder, in my mind, that's a harder
00:23:45.980 thing to prove. And personally, I have no interest in convincing you of that because I'm not convinced.
00:23:51.460 So I think this is an area where the field is in flux a little bit. And there are certainly
00:23:56.000 scientists who I respect a lot in the field who believe at their core that these epigenetic clocks
00:24:02.840 tell us about biological aging or can be used to tell us about biological aging.
00:24:08.200 Then there are people like me who want to see the proof. And I think the proof is really
00:24:12.340 being able to show at an individual level, that could be in a mouse, could be in a person,
00:24:18.400 could be in a dog. At an individual level, you can predict someone's biological age at some point
00:24:24.720 in their life and with some level of precision, predict what's going to happen in the future.
00:24:30.380 What are their future health outcomes? How long are they going to live? Nobody has done that yet.
00:24:35.960 What they've done comes close, I guess. So what has been done is to look at longitudinal studies
00:24:41.660 in people where we have samples from people 10, 20, 30 years ago, measure the epigenetic profiles of
00:24:50.200 those people 10, 20, 30 years ago, and ask how well does that correlate with mortality outcomes,
00:24:56.060 for example, in the future. And they do work to some extent. I think people will debate how well
00:25:02.800 they work. Are they any better than other markers you could look at in predicting mortality? I think
00:25:08.080 that's unclear, but there is some correlation there. So it really depends to some extent maybe
00:25:12.780 on how skeptical you are. I'm a skeptic by nature and I want to actually see the proof. I guess the last
00:25:17.680 thing I would say about this, I'm talking mostly about the epigenetic clocks. Maybe it's worth talking
00:25:21.740 about other types of clocks that people can make. The other thing I want to caution people on though
00:25:27.100 is assuming that the epigenetic clocks are the only important thing about aging. There is again,
00:25:32.720 a small number of very vocal and popular people in the field who talk as if changing the epigenome is
00:25:42.660 going to change everything about aging. We have no data to support that. I just have to say it,
00:25:48.000 that is not true at this point. We have no data to support it. What we know about the biology of
00:25:53.660 aging is that epigenetic changes are one of, depending on how you categorize things, you know,
00:25:59.760 eight or nine or 10 molecular processes that seem to contribute, that the field has reached consensus
00:26:05.120 on. It's only one of those things. Is it possible it is sort of in a hierarchy, the most important and
00:26:10.980 drives a lot of those other changes? Yes, that's possible. We don't have any data to support it. So
00:26:16.120 this idea that reversing the epigenome is reversing aging is at best an exaggeration,
00:26:24.940 at worst, an outright lie. I mean, it's just not true.
00:26:29.260 What a set of experiments technology-wise would you need to be able to do to even test that hypothesis,
00:26:34.080 say, in a mouse?
00:26:34.780 We're close. Well, maybe close. I guess I should qualify that a little bit. Conceptually,
00:26:39.320 we're close. So there have been these factors called the Yamanaka factors that can reprogram the
00:26:45.720 epigenome. So this has been done in cells. So if you take cells in culture, in a laboratory,
00:26:50.700 and you passage them many, many times, you can see changes in the epigenome, just like you might see
00:26:56.220 changes in the epigenome in an animal, in tissues. And you can put these reprogramming factors into
00:27:01.800 the cells and turn them on. Now there are four Yamanaka factors?
00:27:04.860 There are four Yamanaka factors, and people are trying different cocktails, adding some other stuff in,
00:27:09.860 taking some stuff out. But yes, there are the four classic Yamanaka factors. And what those factors do
00:27:15.440 is they basically wipe clean the epigenetic changes that have happened over time. And also,
00:27:22.840 what's amazing is that they restore those cells back to a, if you take it far enough, back to a
00:27:27.960 pluripotent state. So essentially, you get virgin new cells that could differentiate into any cell type
00:27:34.240 in the body. So this has been known for many years. What is relatively more recent over the last
00:27:39.360 eight or nine years are people are trying to express these reprogramming factors in an animal.
00:27:46.580 So instead of doing it in cells in the laboratory, do it in an animal. And I think the most compelling
00:27:50.760 work is work in a premature aging model of mice. So it's called a progeroid model, where they're very
00:27:57.020 short-lived, they're very sick. But these reprogramming factors can extend lifespan by, I don't remember what
00:28:02.880 the exact numbers are, but a significant amount, maybe 40, 50%.
00:28:05.820 Well, which seems like a lot, except you have to recognize these mice live maybe 25% of the length
00:28:11.580 of a normal mouse, right? So they're very sick. But there are impressive changes that happen that
00:28:16.680 are consistent with the idea that you fixed or made something better. So the experiment to do
00:28:21.320 would be to express these reprogramming factors in an old mouse and make that mouse young again.
00:28:27.060 And this is where I think the exaggeration, I'll use the nice word, has gotten ahead of the actual
00:28:32.980 data. So what has been done is showing that in one or two, maybe three tissues, you can see an
00:28:41.240 improvement in function. The most impressive, I think, is work from David Sinclair's lab, where they
00:28:45.400 use this optic degeneration models. So degeneration of the eye showed that they could reverse that with
00:28:51.660 these reprogramming factors, and then tried to do the same thing in an old mouse. You know, the data was
00:28:56.300 mixed, but I think pretty compelling that you could, to some extent, regenerate the optic nerve in an
00:29:00.980 old mouse. So that's certainly impressive, exciting. But nobody has ever taken an old mouse and turned
00:29:07.520 it into a young mouse. So when people start talking about reversing aging, that implies that you have
00:29:13.600 taken an old animal or person, and to some extent, biologically made them young again, that hasn't
00:29:20.360 happened. So what I would say needs to happen to really convince me, there are two things. So I would
00:29:24.940 be convinced that this is useful, potentially therapeutically and important. I'm actually
00:29:30.260 already convinced it could be useful therapeutically. But I would become really excited if somebody could
00:29:34.540 do as good as rapamycin in a mouse. So I'm not asking for much, in my view. We know rapamycin can
00:29:39.860 extend lifespan 25% at least. Again, a dose hasn't been optimized, but 25%, let's stick with that.
00:29:47.140 And you can reverse functional declines in many tissues. So show me you can do that with
00:29:53.360 reprogramming, and I'll be excited. Nobody's done even that yet. Show me you can take a two
00:29:58.980 and a half year old mouse, make it look like a one year old mouse, and then it lives to be five
00:30:03.760 years old. I'll be really excited. Look, I'll be all on board. I might even come on your show and
00:30:07.980 apologize for saying that people were exaggerating, although they are exaggerating now. But I think the
00:30:13.520 enthusiasm has just gotten so far ahead of where the science is. Let's maybe help folks understand
00:30:19.380 what the Yamanaka factors are doing and how one can be sure that even if you fix the aging problem,
00:30:29.680 you don't create a new problem. So if the objective is, I want to take the DNA as I had it when I was
00:30:36.280 young. So when I was 20, this is what my DNA looked like. Now that I'm 50, it looks different.
00:30:43.600 It has literally these methyl groups that are sitting directly on the cysteine residues,
00:30:50.960 like literally on my DNA. Okay, we want to take those off. Maybe?
00:30:55.400 First of all, it's important to understand why that's even a problem.
00:30:58.360 Why is my 50-year-old crappy DNA not as good as my 20-year-old DNA?
00:31:04.140 So again, this is taking a step back to sort of basic biology. So the DNA is where all the
00:31:09.480 information is. But then that DNA has to get turned into RNA. That's called transcription
00:31:14.740 or gene expression. We'll just call it gene expression. And then that RNA has to get turned
00:31:18.420 into protein. And in general, it's the protein that does the work. So what these epigenetic
00:31:22.620 changes, the methyl groups that you were talking about, do primarily, we think, is affect expression
00:31:28.720 of the genes. So basically what you're seeing with aging, we think, is a shift in the epigenome
00:31:35.980 that leads to certain genes being expressed that shouldn't be and certain genes not being
00:31:41.140 expressed that should be. And I think there's a little bit of a debate about which is more
00:31:44.700 important right now, but it probably doesn't really matter, right? So the idea is you're
00:31:48.220 getting things turned on and turned off inappropriately as we get older. So there's a loss of regulation,
00:31:53.360 which probably contributes to a loss of homeostasis. And homeostasis is, I think, a really useful
00:31:58.240 way to think about aging. If you're healthy, your body is generally in homeostasis.
00:32:03.700 And what happens as we get older is it becomes harder and harder for our body to maintain
00:32:08.340 homeostasis. When you get out of homeostasis, if your defense mechanisms are working right,
00:32:13.080 you can get back in. So you get COVID, for example, your immune system works, you're out
00:32:17.100 of homeostasis, but you come back in and then you're okay again. I think as we get older,
00:32:20.820 it gets harder to come back into homeostasis. And that's why we start to see pathology and mortality.
00:32:25.540 So let me differentiate two states of pathology. My five-year-old son was on his scooter
00:32:31.860 two weeks ago, going down the steepest hill in the world, which I had no idea how I didn't see
00:32:36.700 that he was about to do that, like face planted. And when he came up, all I could think is how
00:32:42.500 quickly can we get to the hospital? I mean, it was a bloodbath. I'm not making this up, Matt.
00:32:47.580 Six days later, there was one little tiny scar. Eight or nine days later, you would have had no idea
00:32:55.520 this kid ripped his face off on pavement. He's five. I get a cut. It's like nine months until
00:33:02.800 the scar is gone. So there's a very clear distinction between a five-year-old's DNA and
00:33:08.280 a 50-year-old's DNA in terms of how he can literally make new proteins that are better than
00:33:14.080 my proteins. Let me stop you there just for a second, because I think this is actually the
00:33:17.320 crux of the question. You said it's a difference in your DNA. Well, I'm asking. I think what I'm trying
00:33:21.060 to get at is that's a clear case of the protein that he makes is better than my protein. He's
00:33:26.220 making much better protein. Certainly functions better. I guess what I was getting at, though,
00:33:29.900 is the one question I think that's really important here is there can be changes to the DNA to the
00:33:34.320 sequence, right? So the sequence of the DNA is the information. Those are called mutations,
00:33:38.440 and those accumulate as we age. And that's honestly what drives a lot of cancer. So we've known this for
00:33:43.380 a long time. The epigenetic changes are sort of on top of this. Yeah, and while it more regulates
00:33:48.100 this expression, I'm wondering how much that factors into the example I just gave.
00:33:52.280 It's a good question. I'm sure it does to some extent. Absolutely.
00:33:54.900 Like what else explains why his collagen is so much better than mine? What are the other
00:33:58.300 factors that go into that? I mean, I think there are probably many reasons why healing,
00:34:03.320 our ability to heal, declines with age. I actually, again, we've talked about this before,
00:34:06.880 I think inflammation is a huge driver of our loss of ability to recover as we get older. So,
00:34:13.280 you know, all sorts of things go wrong if you have a high level of sterile inflammation in your
00:34:17.860 body, including the ability of stem cells to function. And a lot of injuries require stem
00:34:22.480 cells to function to build back what's been broken. So it's complicated, I guess I would say,
00:34:27.220 but the question is... Yeah, it could be that I have more senescent cells and more senescent cell
00:34:30.440 factors that are impairing the ability of cells to heal.
00:34:34.280 Just to throw a wrench in that, there's actually a body of thought that senescent cells actually
00:34:37.920 promote wound healing. Again, this is where the biology is so complicated. But I think the crux of
00:34:42.500 the question we started from is, if you only fix the epigenome, do you fix everything?
00:34:46.860 How do you know you fix all these things?
00:34:47.980 Yeah, do you fix everything? And nobody knows, I think is the fair answer. I would be shocked if
00:34:54.160 that was the case, that epigenetic changes drive all of aging. But it's possible. I think we have
00:35:00.160 to be open to that idea that epigenetic changes sit on top of or upstream of the other hallmarks
00:35:06.660 of aging. First of all, let me say one thing. It won't fix everything. You will not fix mutations
00:35:11.200 by fixing the epigenome. The question is, do mutations, do they happen with enough frequency
00:35:18.000 to be a major contributor to functional declines that go along with aging? Certainly cancer you
00:35:25.080 can point to. Well, cancer for sure. But let's now talk about something else, which is near and dear
00:35:29.040 to your heart, no pun intended, but ejection fraction. Again, because you study dogs, not only is
00:35:34.420 cancer a big problem, but so is heart failure. So now we're dealing with a muscle, a set of cells
00:35:41.100 that really aren't being turned over the way skin is. So when we think about the example of my son,
00:35:45.980 when you think about your gut epithelium being sloughed off when you get sick, when you think
00:35:49.500 about your fingernails in your hair, boy, it's really easy to think about those things as rapidly
00:35:53.960 being turned over. But neurons, cardiac myocytes, these things don't get turned over a whole heck of a
00:35:59.460 lot. So what is it about reprogramming that we think is going to fix an aging neuron or an aging
00:36:08.340 cardiac myocyte? This is an area where the biology of what's really happening, at least to my knowledge,
00:36:14.480 is so poorly understood that I think the real answer is we don't completely know. I'm going to
00:36:18.740 give a very simplistic answer, which is that what people are trying to do is not reprogram all the way
00:36:26.540 back to the pluripotent state. So it's called partial reprogramming. It should be pretty dangerous.
00:36:30.420 Well, that's what I was going to say. If you're a single-celled organism, no problem going back to
00:36:33.920 the pluripotent state. You can then start over. In a complicated animal, if we reprogram you back to
00:36:40.620 the pluripotent state, that's not going to end well. No. Right? So I think the idea is to go back
00:36:45.040 far enough that you restore the epigenome to its pristine state, young state, and then hope that when you do
00:36:54.520 that, you restore gene expression to where it's supposed to be. Maybe one way to think about it
00:37:00.180 is you restore the homeostatic mechanisms to a more youthful state where then the homeostatic
00:37:06.680 mechanisms that all of our cells have can basically clean up the rest of the mess. Because we know as
00:37:11.660 we get older, for example, we all accumulate damaged mitochondria. Changing the epigenome, which is the
00:37:17.120 nuclear genome, isn't going to fix anything that's wrong with your mitochondria directly. But maybe by
00:37:22.460 fixing the epigenome, you restore the homeostatic mechanisms that then maintain mitochondria in a
00:37:28.960 healthy state, and you can fix the damage to the mitochondria. So that's the concept. And again,
00:37:35.060 I would say the evidence is suggestive that if you do it just right, you can improve function in at
00:37:42.900 least some aged tissue organs by partial reprogramming. I've yet to see anything that
00:37:48.620 convinces me that anybody has made an old heart into a young heart in an old animal with partial
00:37:54.740 reprogramming in the heart. But you can improve function. I would also say the same thing's true
00:37:58.440 with rapamycin, right? I would not argue. We see that short-term treatment with rapamycin in mice
00:38:04.200 makes an old heart function functionally, to some extent, more like a young heart. I would never argue
00:38:09.940 that we have taken that heart and now it's young. It's just in an old body. We don't know that,
00:38:14.340 and that's hard to prove. You can see some evidence that it should be possible with partial reprogramming
00:38:19.580 to do that. And the question is, will it work everywhere? Will it work in some tissues and
00:38:24.900 organs and not in others? We don't really know. So let's just say 10, 20 years from now, people
00:38:30.540 have figured out a lot of the complexity, starting to move these things into the clinic. Maybe we will
00:38:35.460 see really large effects on lifespan and healthspan in mice. What I've yet to hear anybody give a
00:38:42.460 convincing explanation of is how you do that in the brain. Because so much of who we are and what we
00:38:48.200 are comes from our experiences and our memories. And so how do you ensure that you can reprogram
00:38:55.420 somebody's brain in a way that isn't going to change that? And I just think that's going to be
00:39:00.000 a really hard problem to overcome. But maybe somebody will figure it out. There are tons of
00:39:04.440 really smart people working in this area, lots of resources going into this area. So I think it's
00:39:08.960 exciting. Again, my big concern is that we don't mislead people into thinking that we're close to
00:39:16.540 reversing aging. And I think it's a problem from the perspective of the general public. I think it's
00:39:20.540 a problem from the perspective of the scientific communities. Other scientists look at that and
00:39:24.000 they're like, this is snake oil. This is just not true.
00:39:26.700 My concern with it is actually in terms of the impact it has on people, which are, hey, this is
00:39:32.900 awesome. This thing's going to get worked out. I can sort of do what I want because in 10 years,
00:39:36.700 they're going to reprogram me. And my view on that is even if that is true, or even if you have a high
00:39:44.660 degree of confidence that that is true, how would you not hedge? You know, again, hedging is such an
00:39:50.360 important part of how companies manage risk. So the difference between good companies and bad
00:39:55.820 companies when it comes to risk management is everything. That's why some companies do really
00:40:00.400 well in economic downturns and others don't. It's basically about risk management. And a very important
00:40:05.280 part of risk management is indeed hedging. So if we think of ourselves each as little companies,
00:40:11.000 you know, you're the CEO of Matt Co. I'm the CEO of Pete Co. I can't think of a more important
00:40:17.140 asset within my company to manage than my own life. Do I have enough money? Yeah. You know,
00:40:22.720 do I have enough fun? Yeah. Those are all important assets, but existing would be the number one asset.
00:40:28.520 And to not take a risk management approach of hedging to that is insane. And yet what I see is
00:40:34.620 so many grand promises of this stuff and nobody's sort of paying attention to what they eat or how
00:40:40.500 much exercise they do, because I don't need to, this is going to be worked out. So the thing that I
00:40:44.660 always find amazing is some of the most vocal advocates for this stuff don't have an ounce of
00:40:48.680 muscle on them. You know, they're overweight or whatever, like they don't look healthy. And I'm like,
00:40:53.060 guys, you can do both. You can believe that in 10 years, we're going to fix this problem,
00:40:57.520 but you could still actually care about your health.
00:41:00.520 No, I think that's a really important point. And having, again, been in this field for a long time
00:41:05.340 now, I think you can just look back over the last 20, 30 years and look at predictions people made on
00:41:10.720 how fast these things were going to come along and get into the clinic. And none of that has happened.
00:41:16.160 So I totally agree with you. Also being in the center of it, I take a view of, again,
00:41:21.700 pretty strong skepticism when people say this is going to happen in 10, 15 years.
00:41:26.580 I honestly have not appreciated that there are maybe a lot of people out there looking at what
00:41:31.880 they read in the New York Times or on CNN and thinking to themselves, oh, I don't have to worry
00:41:36.900 about this. This is going to get worked out. So my advice would be don't expect major changes in
00:41:44.220 treatments to improve lifespan and healthspan in the next 20 years. And that doesn't mean I'm not
00:41:50.020 optimistic. I think there are opportunities there. It would not surprise me if we do see
00:41:54.940 some of these things get into the clinic, but I certainly wouldn't expect it because there are
00:41:59.040 so many barriers that we don't yet appreciate. There are lots of barriers just in moving something
00:42:03.960 through the clinical trial process. I think the reprogramming stuff is a perfect example.
00:42:07.840 So you actually alluded to this earlier. Are there potential side effects? Absolutely.
00:42:12.000 You push it too far, you reprogram too far, you're gone. We know that certain types of cancers
00:42:17.940 are a side effect of this partial reprogramming in mice. Again, it doesn't mean it can't be worked
00:42:22.400 out, but there are really reasons I think to be concerned that this is going to be hard
00:42:26.720 to implement therapeutically. The other thing I would say, even if those things can be worked out,
00:42:32.420 the FDA is going to be extremely skeptical of this kind of approach. So as people move these through
00:42:38.140 the clinical trial process, they are going to have to show with really rock solid, compelling data
00:42:43.780 that reprogramming strategies are not going to cause significant side effects. So I think it's
00:42:48.100 a long road before we have reprogramming strategies that get into the clinic. Maybe somebody will
00:42:54.380 identify a small molecule that can do some of this. And I know people are working on that. Maybe
00:42:58.520 that'll be an easier path. But for now, I think it's going to take a while. That's the best case
00:43:02.700 scenario. That's if we really can partially, I'm going to say partially reverse aging, reverse
00:43:07.260 aspects of aging. It's still going to be a long road.
00:43:09.960 And I wonder if the first wins are going to be things like what David Sinclair has done,
00:43:14.420 where you've got one very niche application. I think another one that would be amazing would
00:43:18.940 be osteoarthritis. If you could figure out a way to regenerate human cartilage without joint
00:43:24.120 replacements, those are huge wins that seem at least a little more feasible. But again, I agree
00:43:30.940 with you. I think this stuff takes four times as long and costs four times as much as we think.
00:43:36.640 You and I are, I mean, honestly, we're pretty lucky because we know about a lot of this stuff.
00:43:40.680 We actually can start practicing some of this stuff like rapamycin before it gets out there,
00:43:45.360 right? Again, I'm not recommending anybody take rapamycin necessarily without talking to your
00:43:50.200 physician first. But we know this stuff and we have at least a pretty good idea of the relative
00:43:55.200 risk reward. But before it gets out to where it hits the mainstream from a clinical perspective,
00:44:01.460 it's a really long path. I totally agree with what you said, though, about specific indications where
00:44:06.840 you can target it very precisely, hopefully, and where there's no other solution currently. I think
00:44:13.560 those are opportunities. That's exactly the strategy that people have tried to take with
00:44:17.280 senolytics, that these molecules that will clear senescent cells. And even that's been hard. I mean,
00:44:22.340 Unity is the sort of largest company in this space and their first clinical trial for osteoarthritis
00:44:27.600 failed. So now they're looking at the eye because it's a nice indication where for some of these eye
00:44:33.380 diseases, there isn't any solution. And you can, in principle, target it quite precisely to the eye.
00:44:39.260 So yeah, I think that is exactly the strategy that people will be taking. And hopefully it'll be
00:44:43.600 successful. I want this stuff to work. I just try to be a realist at the same time.
00:44:48.420 The way I would kind of describe this to people is if you want to bring it back to a financial
00:44:51.660 analogy, it's a lottery ticket. And so if your entire financial planning system is based on
00:44:57.940 winning the lottery, the odds that you're going to win are pretty low. Instead, if you're going to
00:45:03.540 play the lottery, play it in the context of an otherwise great saving and investing strategy.
00:45:09.080 I guess the other thing I would add to that is, and this is what we talked about before,
00:45:12.440 you don't have to do everything right. Get 80% of the way there, which nutritionally I don't think
00:45:17.300 is, I mean, for some people it's very challenging, but I think most people could do that.
00:45:20.540 But exercise, you don't have to optimize your physical activity. Do something and that'll
00:45:26.200 get you most of the way there. So yeah, I totally agree.
00:45:28.240 Yeah, the exercise curve, which we've covered a lot in previous podcasts, you get most of
00:45:33.240 the benefit. I would say literally 50% of the benefit based on at least the so-so epidemiologic
00:45:39.540 data, about 50% of the full benefit of exercise is captured going from nothing to about 15 met
00:45:48.320 hours per week. You know, that would be 15 mats times one hour would be one way to get there.
00:45:53.760 But in reality, no one who's that unfit is going to do 15 mats, but that would be like
00:45:57.320 three hours a week of five mats to put that in perspective. And five mats is like a very,
00:46:03.560 very brisk walk or a slow jog, something to that effect. So you get a sense of like 15 met hours per
00:46:09.400 week. By extension, I do about a hundred met hours per week of exercise. I think of everything in terms
00:46:14.580 of met hours. But the point is that you can get, depending on the study, 30 to 50% of the benefit
00:46:20.420 going from being completely sedentary to 15 met hours per week is pretty amazing.
00:46:25.780 Which is a big benefit, right? And again, it's sort of remarkable that that information isn't
00:46:30.020 out there. And for the most people in the general public don't know that. I don't know what the
00:46:34.840 solution is. I think you're obviously doing a great public service by trying to get that
00:46:38.760 information out there. But it's unfortunate because I think, again, most people understood how much
00:46:43.520 benefit they could get from just getting out and moving a little bit. Maybe a lot, maybe three
00:46:49.180 hours a week is a lot for some people. But the magnitude of the benefit compared to the effort
00:46:54.200 that you put in, I think most people just don't know that. And it's unfortunate.
00:46:58.020 Let's go back to the CR stuff. So what do we know about the effect of CR in the laboratory animals
00:47:04.840 on the immune system?
00:47:06.020 So it's a little bit complicated. First of all, laboratory animals in the laboratory are kept in
00:47:12.380 what's called a specific pathogen-free environment. So that doesn't mean there's no pathogens,
00:47:16.380 but it's a relatively low pathogen environment where they are not obligated to really use their
00:47:22.660 immune systems against all the challenges that we would face in the real world. So one question
00:47:27.880 has come up. Are animals that are on calorie restriction immune compromised? And again, I think
00:47:33.400 the data is a little bit mixed. There have been studies where people have done pathogen challenges
00:47:38.320 on CR animals and they respond better. At least the old animals respond better than age-matched
00:47:43.280 ad libitum fed control. So ad libitum just means eat as much as you want. But then for certain types
00:47:48.080 of challenges, caloric restriction clearly causes a deficit.
00:47:51.700 Yeah, the sepsis experiments are pretty clear. With the CR animals compared to controls, when you
00:47:56.300 induce sepsis in them, the CR animals die much more quickly.
00:47:59.640 And so, of course, the obvious implication of that is that maybe CR would impair immune function in
00:48:05.080 people and lead to higher risk of all sorts of infectious diseases. And this gets additionally
00:48:10.540 complicated though by the question of optimal CR with optimal nutrition. So you might sometimes
00:48:15.600 just see this CRON, C-R-O-N, right? Caloric restriction with optimal nutrition or CRAN,
00:48:20.860 caloric restriction with adequate nutrition. That can be done in a mouse. We can control all of that.
00:48:25.920 So we make sure that they get all the micronutrients and vitamins that they need
00:48:29.200 when they're on this CR diet. When you move into the real world and people start practicing caloric
00:48:35.820 restriction, that all goes out the window. If I wanted to do caloric restriction off the top of
00:48:40.180 my head, I wouldn't even know what to do to make sure that I'm getting optimal nutrition.
00:48:44.440 And so in that state where you are CR without optimal nutrition, I think that's where I really
00:48:50.200 become worried about the side effects, particularly as you raised immune deficits, because you may not
00:48:56.500 be getting the nutrient value or the specific micronutrients and vitamins that you need
00:49:02.600 to maintain a functioning immune system. Sure, you may affect some aspects of the biology of aging in a
00:49:09.160 way that you're aging biologically more slowly. That doesn't matter if you get influenza and die.
00:49:15.240 So again, I think that's an additional complication that comes into play. When we start talking about,
00:49:19.660 we haven't talked about all the other anti-aging nutritional strategies. When we start talking about
00:49:24.440 recommending those nutritional strategies to the general public, based solely on mouse studies,
00:49:31.580 I get really concerned because of this environmental complexity that humans live in.
00:49:38.140 And we haven't even talked about the genetic complexity, right? So there's all sorts of things
00:49:41.160 that are just different about laboratory animals compared to people living in the real world.
00:49:46.880 And then what can we say about frailty, sarcopenia, as it changes in an animal in a CR environment,
00:49:54.280 and can that be extrapolated also? It's pretty clear, I think, that much like rapamycin,
00:50:00.100 most functional measures of aging seem to be preserved in calorically restricted animals,
00:50:05.060 including measures of frailty and measures of sarcopenia. The same thing, again, is true with
00:50:09.500 rapamycin. This actually surprised a lot of people when the first studies were done because the
00:50:14.120 expectation was, because mTOR plays such a big role in muscle synthesis, that if you inhibit mTOR with
00:50:20.700 rapamycin or caloric restriction, which is a potent inhibitor of mTOR, that you would actually see
00:50:25.700 accelerated sarcopenia. And that just isn't the observation in laboratory animals. Again, we have
00:50:30.460 to be careful not to extrapolate to people, but it doesn't seem to be the case that you lose muscle
00:50:35.680 mass and function in the way that people would define sarcopenia. I think the important complication
00:50:41.380 here is that all of the caloric restriction studies that I'm aware of, when they look at muscle
00:50:46.260 function, normalized to body weight. And the calorically restricted mice weigh substantially
00:50:51.320 less than the ad libitum fed mice. Usually, I think it's on the order of 30, 35% less.
00:50:56.540 So it's usually grip strength normalized to weight.
00:50:58.960 Right. So what you're actually seeing is that the calorically restricted mice have maintained muscle
00:51:07.040 function proportionate to their body weight. And I don't know the answer to this, but it's something
00:51:12.320 that I thought of when we were talking about this show. Let's just say you did that in a person.
00:51:17.240 You would be able to answer this. I'm sure you've got a 60-year-old person who needs to lose 30% of
00:51:22.400 their body weight. But of course, you want to maintain their muscle mass, their muscle function.
00:51:26.960 Would you view it as a good thing or a bad thing if they lost 30% of their body weight and 30% of their
00:51:34.900 strength?
00:51:35.220 I don't think we would. And I don't think we would view it as a good thing. If you're telling me that
00:51:39.300 someone needs to lose 30% of their body weight, presumably their body composition isn't great to
00:51:43.460 begin with. So no, I think you would view that as maybe a better thing than where they started,
00:51:49.840 but not optimal either. Optimal might be you would lose 30% of your body weight, but it would
00:51:56.520 disproportionately be adipose tissue, and you might only lose 10% of your strength or none at all,
00:52:01.440 depending on the change in lean body mass.
00:52:03.220 This is just a complication of the CR studies. It's hard for me sometimes. It takes me 20,
00:52:08.180 30 minutes of trying to dig through the paper to really figure out what normalization did they do
00:52:13.460 to look at metabolic rate or muscle mass or lean mass or fat mass or muscle function. But usually,
00:52:19.780 these studies will be normalized to body weight. This actually comes up also in some of the
00:52:24.700 intermittent fasting studies where the question sometimes in these studies is, are they
00:52:29.600 isocaloric or are they calorically restricted when they're put on intermittent fasting?
00:52:34.240 And people will claim they're isocaloric, but the mice lose weight. And what they really are is
00:52:40.120 isocaloric when normalized body weight, right? So they're really calorically restricted, but you have
00:52:45.040 to kind of dig to get how the normalizations were done to really understand.
00:52:50.260 When we think about what we know in humans, you know, there was a study that looked at the
00:52:54.320 difference in bone mineral density in people who underwent equal amounts of weight loss,
00:53:00.000 one driven by a caloric restriction strategy, one driven by an exercise-driven strategy.
00:53:05.720 And the exercise-driven weight loss group did not experience a reduction in BMD, but the CR group did.
00:53:11.580 Yeah.
00:53:12.180 So, you know, that's interesting. That's yet another thing that makes you think there's a little more
00:53:17.180 nuance to this, which is not to say CR from a weight loss perspective isn't valuable,
00:53:22.540 but it begs the question, is CR the right tool for longevity? Once you've achieved optimal weight,
00:53:29.380 is additional CR beneficial?
00:53:31.640 Well, that makes the assumption we know what optimal weight is. I mean, I think that's kind
00:53:34.620 of the crux of the question, right? We're asking, does CR impact longevity positively? We know if you
00:53:41.080 go on CR, you're going to lose weight. So if the answer to that is yes, then by definition,
00:53:44.780 optimal weight is lower than what we think, right?
00:53:47.440 Well, in humans though.
00:53:48.620 I would say we still don't really know what optimal weight is. So again, this, I think,
00:53:53.860 just reflects the challenges in coming to definitive answers. And the way I think about
00:53:59.140 it more so is what are the downsides potentially to caloric restriction? And if we don't know that
00:54:06.180 caloric restriction has big benefits in terms of health span and perhaps lifespan, what are the
00:54:12.920 downsides? And do those downsides outweigh the uncertainty we have about whether caloric
00:54:18.480 restriction is beneficial? And unfortunately, I think this is something that not very many people
00:54:23.640 in this field pay attention to. We all expect if you do a clinical trial of a drug, you're going to
00:54:29.480 report adverse events and you're going to look at side effects. Very rarely do people think about
00:54:34.500 that before they write a book recommending that people should do diet X. Even in the clinical trials,
00:54:40.140 some of the nutritional clinical trials, they don't really carefully monitor adverse events.
00:54:45.880 It's a bias in the way we think about interventions. We feel like nutritional interventions
00:54:51.220 are by their very nature safe. And certainly for extreme nutritional interventions, that's clearly
00:54:56.960 not true. So I think we should be thinking about what are the risks associated with significant
00:55:01.540 caloric restriction in people as a therapeutic strategy.
00:55:05.840 So let's talk about the experiment to end all experiments with respect to caloric restriction,
00:55:09.440 which is the very famous one we alluded to earlier at the University of Wisconsin and the
00:55:14.040 NIA. I've read this study a thousand times. If I can get the details right once, I'll be happy.
00:55:19.660 But between the two of us, I hope we can do this. You had two groups of animals, one at the
00:55:24.160 University of Wisconsin and one directly in Bethesda, Maryland. This was obviously a huge NIH funded
00:55:28.440 effort. It ran for a couple of decades given the lifespan of rhesus monkeys. The Wisconsin animals
00:55:35.580 were fed, the controls and the treatment CR animals were fed a very processed diet. At least after the
00:55:44.040 fact, the investigators there suggested they wanted to more mimic a standard American diet. Of note,
00:55:49.860 I recall the amount of sugar, pure sucrose in their diet was 28.5% of total calories. So a high quality
00:55:58.580 diet facetiously, the CR animals, the calorically restricted animals were fed 25% of what the control
00:56:06.460 animals were fed. And in that experiment, we found a benefit to caloric restriction. The CR animals
00:56:13.300 outlived the control animals.
00:56:15.800 And they had fewer age-related diseases. So I think if you go back to that original 2009 paper, you know,
00:56:21.220 the lifespan effect is compelling and it looks real. But what again is really indicative of that it might be
00:56:27.740 having an effect on biological aging is that they saw reduced rates of cancer. Again, not surprisingly, as we
00:56:33.680 talked about in mice, but also heart disease and metabolic disease. So it's consistent with the idea that in
00:56:40.900 that cohort of monkeys, again, given what you mentioned about the dietary composition, caloric restriction was in
00:56:47.940 fact having a beneficial impact on the aging process.
00:56:52.300 And those animals all came in at about the same age.
00:56:55.440 So that was sort of an apples to apples comparison.
00:56:59.300 Now we go down the road to Bethesda. We have a totally different experiment in a way.
00:57:03.540 I don't know how much of this was deliberate and how much of it was not.
00:57:06.540 The diets were different. So that's maybe a good contrast. These animals were actually fed the closest
00:57:12.740 diet that could mimic their real diet. It didn't have any, you know, sugar in it really. I think it was
00:57:18.040 like about 3% sucrose. It was almost kind of like a vegetarian, pescatarian sort of diet.
00:57:24.320 Fish was the dominant source of protein. You know, it was a high quality diet relative to the
00:57:28.800 Wisconsin animals.
00:57:29.740 Higher quality for sure.
00:57:30.660 The complicating factor here was the animals didn't come in at all the same age. So you had
00:57:38.600 some animals that came in young, some animals that came in old. The net result of the study was there
00:57:44.160 was no difference. The CR animals did not outlive. And so while the Wisconsin study was first published
00:57:49.660 in 2009 and it said CR works, the 2012 publication for NIA said CR doesn't work. At least that's the
00:57:57.420 lay press interpretation of it. So how do you kind of reconcile these findings?
00:58:01.640 One thing to add to that is the NIA study at Bethesda, in their paper at least, they did show some
00:58:08.440 evidence for improvements in at least some healthspan metrics. So if you read that paper closely, I think
00:58:13.880 what they're really saying is CR didn't extend lifespan, but it did have what appear to be some
00:58:18.780 beneficial effects on healthspan metrics. So it wasn't a complete failure in that sense. I mean,
00:58:23.800 I think it's interesting because since then, I remember when the 2011 paper came out, the Wisconsin
00:58:29.120 people were pretty upset, understandably so, I think. Since then, they've had sort of a reconciliation
00:58:33.540 paper and where they try to figure out what does it mean that we got these different results.
00:58:38.480 And I think their conclusion, which certainly is plausible, is that a lot of it comes down to the
00:58:45.040 difference in diets. And if you look at the actual body weights of the animals and how much food they
00:58:50.040 ate, not just the composition, but actually how much they ate, you know, you could make an argument
00:58:55.020 that the Bethesda monkeys were somewhat slightly calorically restricted.
00:59:00.220 The controls.
00:59:00.940 The controls, yeah, sorry.
00:59:01.940 Yes. The controls at Bethesda ate less than the controls in Wisconsin. And that would have
00:59:08.580 narrowed the gap between them and the treatment. And so then I think, as you also alluded to,
00:59:13.060 the fact that the Bethesda study was a little bit less controlled for age of onset. I don't remember
00:59:19.740 the details exactly. There were also some genetic differences in there. So there's a combination of
00:59:23.940 factors that make it a little bit difficult to conclude that it all is about the diet. The monkeys
00:59:30.440 in the Bethesda study came in at different ages. There was at least a hint, I think, that the
00:59:35.040 monkeys that came in at older ages, started CR at older ages, maybe got somewhat of a benefit,
00:59:41.020 whereas the ones that started early didn't get any benefit. So it's complicated to interpret. And
00:59:45.600 it's interesting because we see this a lot of times in the basic biology of aging, basic science
00:59:51.500 studies, where different labs will get different results in what seems to be the same exact experiment.
00:59:57.680 And then you start to dig into it. And yeah, there's all these differences in the way it was
01:00:01.860 done. It's really hard to know which of those differences contributed to the different outcomes.
01:00:07.000 In this particular case, because it was a 30, 40-year experiment, we're never going to find out.
01:00:11.860 That can't be done again.
01:00:12.680 Yeah, it just won't be repeated, both because of how long it takes and also because
01:00:16.360 the view on primate research, these are rhesus macaques, the view on primate research publicly has
01:00:23.360 changed. I just don't think we'll ever see that experiment done again.
01:00:26.380 My gut feeling is that the Wisconsin study, to some extent, probably does mirror what is closer
01:00:35.140 to a typical American situation, at least these days. I do not believe that they started with
01:00:41.780 that intention. But where we're at today, it probably is relatively as close as you can get
01:00:47.260 for a controlled laboratory study. The question, though, in my mind is, between these two studies,
01:00:52.420 do they suggest that caloric restriction slows aging? And let's just start relative to the
01:00:58.060 typical American diet. Somebody is moderately obese and they're eating terrible. Is it caloric
01:01:03.240 restriction or is it just returning to what you would call like an optimal body weight,
01:01:09.260 optimal body mass? And I don't think we know the answer. From these studies, you can't draw many
01:01:14.660 conclusions. I think the one thing you can do, and Roz Anderson, who's still at Wisconsin,
01:01:19.220 has really, I think, been a leader in this, is you can study the molecular signatures of caloric
01:01:26.700 restriction in the monkeys and ask, does it look similar to the molecular signatures of caloric
01:01:33.000 restriction in rodents? And you might ask, well, why would you do that? It seems obvious. But again,
01:01:37.640 a lot of the questions that people have around caloric restriction studies in mice is,
01:01:41.940 will it work the same way in people? And obviously, rhesus macaques are much closer
01:01:48.180 evolutionarily to people than mice are. So if you see the same molecular changes, it's suggestive that
01:01:54.960 caloric restriction is having the same molecular changes in people, certainly in primates. And in fact,
01:02:00.440 that seems to be the case. A lot of what we see in terms of, you know, changes in mTOR signaling
01:02:05.860 and mitochondrial function and other metabolic pathways is, in fact, shared between mice
01:02:11.880 and monkeys. That is one important outcome from these studies that we can definitely say is
01:02:16.820 rock solid. I tend to believe that the pretty dramatic declines in age-related disease seen in
01:02:24.400 the Wisconsin studies are telling us something. But again, is it just telling us that not being obese
01:02:30.240 reduces your risk for a lot of these diseases? We kind of already know that from the human literature.
01:02:35.380 Exactly. The other thing that isn't entirely clear, given that the NIA study didn't find a
01:02:41.840 difference, is we don't know how much of this was the CR versus the DR, the dietary restriction.
01:02:48.380 In other words, what the Wisconsin experiment suggests is, if you have an awful diet, reducing
01:02:55.280 the amount of awful food you eat is a good thing. Right.
01:02:59.240 What the NIA experiment doesn't tell us is the contrapositive. It doesn't suggest that if you
01:03:05.420 have a good diet, eating less of that will help you live longer. It might, but it isn't definitive.
01:03:11.040 So we don't know if the Wisconsin animals lived longer simply because they lost weight or because
01:03:16.460 they lost weight and they were eating less processed food.
01:03:20.360 Right. And I think the other thing to add to that is the NIA monkeys, which were eating,
01:03:25.160 you know, what we'll call a superior diet to the Wisconsin monkeys, also ate less than the
01:03:29.460 Wisconsin monkeys. In total, yeah.
01:03:31.180 So in other words, if you ate more of a good diet, would that be detrimental? We also don't know that.
01:03:36.520 It's an interesting question, actually, and it's too bad we don't know the answer to that. But I think
01:03:40.720 if they had been body weight matched or caloric consumption matched, that would have been an
01:03:47.100 interesting comparison to be able to see are there differences there.
01:03:50.640 And the other thing that just kind of gets off into weeds that we don't need to necessarily go into
01:03:55.060 is I don't really have a great understanding of even how we differ from the rhesus monkeys.
01:04:01.560 So, you know, I recently read Herman Ponsner's book. I don't know. Have you read it, by the way?
01:04:05.500 No.
01:04:05.660 So he kind of goes into the ecology and evolution of humans as a species and how different we are,
01:04:11.320 even from our closest evolutionary cousins. And one of the fundamental differences are incredible
01:04:17.940 capacity to store excess energy. So our metabolic rates, you know, he documents this through lots of
01:04:24.520 assessments of doubly labeled water on not just ourselves, but also hunter gatherers that are
01:04:30.440 still around today. And then of course, all the primates is we're really kind of unique in our
01:04:35.980 energy expenditure. Our energy needs are far greater than anything else. And people like that would argue,
01:04:42.700 hey, that was kind of an advantage that we took to allow our development, including our brain
01:04:48.600 development. So there's kind of a reason we're at the top of the food chain, which is we have a much
01:04:55.140 greater brain. And the price we pay for that is higher energy expenditure. And the price we pay for
01:05:01.840 that is we better be able to store energy because we will have a much harder time tolerating a low
01:05:08.520 energy environment. And so he talks about how even when you put these animals in captivity and you overfeed
01:05:14.560 them, they're not getting that much fatter. They're actually putting on lean mass. You know, I think
01:05:19.620 what you could argue, and he doesn't talk about this, but knowing what we know about human biology, you
01:05:24.160 might argue that they're still getting metabolically sick. Just as humans, when you're overfed, the real
01:05:29.620 metabolic sickness comes not with the inflation of your subcutaneous fat. It's when that spills out into the
01:05:36.680 viscera, into the liver, into the peripancreatic space, into the perinephric space, into the pericardial
01:05:42.820 space. It's that fat that escapes the normal depot of sub-Q fat that is truly inflammatory and truly
01:05:50.000 metabolically disturbing. So I throw all that in there just to say, like, it's just one more
01:05:54.220 confounding variable that makes it difficult to compare us even to an organism as complex as a
01:05:59.540 rhesus monkey. People certainly have made that criticism of the caloric restriction literature
01:06:04.660 writ large, not even taking into account the monkey studies, but the mouse studies, right? That there
01:06:09.600 are all sorts of differences between people and mice, and the metabolic state that people have
01:06:16.980 evolved to fill is just completely different. Having said that, you're absolutely right that
01:06:21.780 even mice in the laboratory as they get older will show metabolic syndrome, right? You will see
01:06:26.260 many of the same changes, insulin resistance, for example, that you see in people.
01:06:32.440 And do you see it absent the adiposity? Can you see it?
01:06:35.380 Mice gain adiposity with age two. They do, in fact, become obese with age. Again, on a pretty
01:06:41.500 crappy diet, right? Well, I don't know if it's crappy or not, the standard mouse diet. I don't
01:06:45.700 remember what the number is you made, but in the Wisconsin study, right, a significant fraction
01:06:49.800 of the control-fed monkeys develop diabetes.
01:06:53.820 Yes. I want to say, like, a quarter of the controls were pre-diabetic by the end of the study.
01:06:58.760 Again, which probably speaks to, even though they weren't overweight, when you get 28.5% of your
01:07:04.320 calories from sugar, it's probably going to impair your metabolism.
01:07:08.180 The other point that's maybe worth at least just mentioning here, because I hear people
01:07:11.700 talk about how certain diets are better for humans because it more mimics what we evolved to eat.
01:07:19.720 I don't know whether that's true or not. You could argue both sides of that. I don't see any
01:07:22.780 particularly compelling reason to think that that was the optimal longevity diet that,
01:07:27.480 you know, humans ate 100,000 years ago.
01:07:29.600 That argument is illogical on several fronts. The first is, and I don't know who coined this
01:07:35.400 phrase, but it's so ubiquitous that it's obvious. Like, by necessity, we had to be opportunistic
01:07:40.940 omnivores to even suggest that our hunter-gatherer forefathers were sitting around pontificating
01:07:47.980 about what they were and were not going to eat.
01:07:50.000 What they should eat, yeah.
01:07:50.640 It's just the dumbest thing I've ever heard. I mean, I don't think people are actually arguing
01:07:54.280 that. But my point is, the argument becomes so nonsensical when you realize our evolution
01:07:59.820 necessitated the most flexibility from a nutritional standpoint.
01:08:04.620 Yes.
01:08:05.200 And therefore, we ate anything and everything. And I think because we never probably existed
01:08:13.700 in an environment where food abundance was so great that we could reach the level of overnutrition,
01:08:20.840 it gave us even more flexibility with what we could eat.
01:08:24.480 Is that maybe part of the reason why humans seem to be fairly robust towards eating really,
01:08:32.820 really crappy diets? Obviously, we have an obesity epidemic and all of that stuff happening. But people
01:08:39.620 seem to be able to tolerate a wide variety of different diets, some of which are pretty darn
01:08:45.580 bad for them for many, many years before you start to really see the significant consequences.
01:08:51.500 And it may be that metabolic flexibility.
01:08:53.100 I was going to make a totally different point that's almost orthogonal to that, which is
01:08:56.720 you can make a case that people can survive in really remarkable health with diets that look
01:09:01.560 nothing like one another. In other words, you can look at somebody eating a really well-formulated,
01:09:07.000 strict vegan diet where they're not getting any animal protein, which clearly our ancestors all had
01:09:13.240 animal protein whenever they could. They're often a little protein malnourished, but they're very
01:09:18.900 healthy. And similarly, look at the opposite end of that spectrum. You can look at somebody on a
01:09:22.240 ketogenic diet. The only thing they would have in common between that other person is probably a lot
01:09:26.540 of leafy vegetables. But other than that, it's a much higher fat, higher protein diet. They can be
01:09:31.160 very healthy. That to me speaks to the resilience of our genome in terms of its interaction with
01:09:38.540 nutrition.
01:09:39.540 And that's sort of where I started, which is that there's no reason to think that the
01:09:43.100 ancestral diet is best. There's no reason to think that. But the other thing that I was thinking
01:09:49.220 about when I started down this path is that like many other things, our, as a species, our dietary
01:09:56.080 options and the typical diet is evolving rapidly now. The quality of the food, the stuff that's in it,
01:10:03.560 the preservatives is dramatically different than it was 50 years ago, both in caloric content and
01:10:09.320 nutritional content and taste and taste. Right. Absolutely. Which contributes to why a lot of
01:10:14.560 people want to eat more. So high calorie, really good tasting food that's often cheap. But the
01:10:19.900 environment that we evolved into obviously is completely different than it is today. But our
01:10:25.300 environment is changing at an accelerating pace, I think. And that makes it really, again, complicated
01:10:31.580 to try to get into the minutiae of what is optimal. Maybe we should be thinking about what's good
01:10:36.500 enough first, right? Because I think it's going to be really hard. And again, this is where I struggle
01:10:41.680 with the data that comes from epidemiological studies of people 20 years ago. The environment,
01:10:48.320 the food quality is just very different for most people today than it was even 20 years ago.
01:10:52.660 Well, this is where the grandmother test comes in. And this is where when I watch like the extremists
01:10:57.420 on both sides argue, I say two things. The first is, look, there are really good and really bad ways to do
01:11:04.560 your respective diet. I don't want to hear somebody tell me that everybody on a vegan diet is doing
01:11:08.800 well because I watched a lot of those kids in college and they literally were going to kill
01:11:13.280 themselves eating ramen noodles and crackers and cookies all day. So you can be vegan and eat pure
01:11:18.300 garbage. You could be keto and eat pure garbage. The second thing I would say is if you're eating those
01:11:23.180 diets well, and I'm being a little subjective when I say well, you're all shopping on the outer part of
01:11:28.800 the perimeter of the grocery store. It doesn't matter if you're carnivore, vegan, keto, low carb,
01:11:35.200 paleo, whatever. If you're doing those diets in the way that they were at least thought to exist,
01:11:41.160 you aren't going down any aisles of the grocery store. And that's kind of this grandmother test.
01:11:46.320 Like if your great grandmother didn't recognize what you're eating, it doesn't mean it's not good.
01:11:52.400 I don't want to say that a protein bar is not a good thing to eat. You just have to acknowledge
01:11:56.800 there's a little more risk there. Eating a carrot is inherently less risky than eating a protein bar
01:12:03.540 with 14 ingredients in it. That's just a fact. I think this is what you're getting at. Just a
01:12:07.880 little bit of a humility around what is known, what is not known. And as we push the envelope
01:12:14.220 of convenience, of nutrient density, of economics, price, shareability, portability, right? The ability
01:12:21.580 to preserve things. We're going to take some risks. Yep. I think that's exactly right.
01:12:25.380 But let's talk about more broadly, a paper you wrote, how long has it been? Two years?
01:12:30.540 We probably wrote it longer than two years ago. I think it came out at the end of 2021.
01:12:35.260 Oh, okay. Okay. Yeah. So it's fairly recent.
01:12:36.960 So talk about the impetus for that paper, which I thought was a great paper and we should discuss it
01:12:40.680 in some detail. Yeah. So I was asked by one of the editors at Science to write a review,
01:12:46.240 I think on mTOR actually. And like, well, lots of people have written reviews on mTOR. I've been
01:12:50.200 thinking a lot about caloric restriction and particularly other nutritional strategies that
01:12:56.200 people have been studying in the field, like ketogenic diet, protein restriction, time-restricted
01:13:02.880 feeding, intermittent fasting. And what do we actually know about those diets and their effects
01:13:08.220 on aging? Because I was of the, before I started to really dive into it, and this isn't something
01:13:12.600 that my lab researches directly. So we've previously done work on caloric restriction in invertebrates
01:13:19.300 and C. elegans, but we never really have done a lot of dietary interventions in mice. You know,
01:13:24.060 before I dove into the literature, I had this impression that all of these diets were similar
01:13:30.400 in some ways and had maybe comparable effects on lifespan. At least that's the way it gets portrayed
01:13:36.520 if you read some of these reviews. And I don't even like to call them reviews because I don't think
01:13:41.340 honestly, much of what gets into the literature as review articles are actually reviews. It's more
01:13:46.520 one person's opinion piece on their specific thing that they study, which is unfortunate.
01:13:52.260 But if you read most of the reviews on caloric restriction and other dietary interventions,
01:13:56.740 they're very one-sided. They usually have phrases like, fasting is known to have all of these
01:14:02.420 fantastic benefits, slows aging in every place where it's been looked at. And you can see that for all
01:14:07.520 these different dietary strategies. So I proposed to the editor that, you know, maybe we should do
01:14:12.360 a critical review of this space and think about what do we know? What do we don't know? Are they
01:14:17.920 equivalent? And to the extent possible, can we gain any insights into whether or not these nutritional
01:14:25.340 strategies, whether there's evidence that they have an impact on the aging process in people? So
01:14:30.000 that's kind of where we started. And I knew it was an ambitious thing to tackle when I said it.
01:14:36.480 And I'm not sure I really appreciated exactly how challenging that was going to be because it's a
01:14:41.820 huge area of literature. And it turns out, maybe not shockingly, that there are many more questions
01:14:48.860 than there are answers when you really dive into it. So what was your process?
01:14:52.680 The first step was, and I should say I had a fantastic set of co-authors, all, you know,
01:14:56.800 really great early career scientists who really helped me with this and did a lot of the legwork.
01:15:01.860 I just want to mention them by name.
01:15:03.040 Please do.
01:15:03.460 So Alessandro Bito, who was a postdoc with me, Mitchell Lee, who was a former graduate student
01:15:08.740 with me, and Crystal Hill, who's at the Pennington Biomedical Research Institute. And she works on FGF
01:15:14.740 21 and protein restriction. So those three were co-authors on this paper with me, all just really
01:15:19.940 fantastic early career scientists. So we started by asking ourselves, okay, what are the different
01:15:24.920 popular dietary interventions that people have claimed have an effect on aging? And we came up with,
01:15:30.920 I don't know, six or seven, the ones I've already mentioned. So there's true caloric restriction,
01:15:35.100 which is pretty straightforward. That really just means limiting the overall caloric intake that an
01:15:41.200 animal gets by somewhere between 20 towards the low end. And the most I've ever seen is 65% of calories.
01:15:48.060 And you were doing this in animals and humans?
01:15:50.160 We were mostly focusing on mice. We narrowed it pretty quickly when we realized the scope of
01:15:54.800 what we had undertaken. So we could have tried to do it in, you know, fruit flies and worms and all that
01:16:00.260 stuff. We said, let's start with mice, see what's known, and then try to look into humans and ask,
01:16:07.260 are there parallels? So caloric restriction, pretty straightforward. We actually don't go very deep
01:16:12.100 into caloric restriction because that literature is huge. And other people I think have done a pretty
01:16:16.000 good job of reviewing true caloric restriction. But there are some points there that we probably
01:16:20.800 want to touch on that are important. And then there are variants of caloric restriction,
01:16:24.340 which include intermittent fasting, time-restricted feeding.
01:16:28.980 How did you differentiate those two? I have a definition, but I want to make sure yours is
01:16:32.600 clear.
01:16:32.860 So in mice, well, so first of all, the first differentiator we need to put across all of
01:16:37.320 these things, is it isocaloric or is it a flavor of caloric restriction? Because it turns out,
01:16:43.960 I would say the vast majority of studies in mice of all of the things that we're going to talk about
01:16:48.600 are flavors of caloric restriction. And what I mean by that is the experimental group ate less
01:16:53.620 calories than the control group.
01:16:54.920 So it's time-restricted feeding, but it's really caloric restriction in a narrower window.
01:16:59.400 Intermittent caloric restriction, maybe is the way you want to think of it. And there's actually
01:17:02.700 some nuance there that we can get to. So how am I differentiating between time-restricted feeding
01:17:06.780 and intermittent fasting? I would say, to my view, the easiest differentiator is time-restricted
01:17:12.300 feeding is limiting the number of hours in any 24-hour period that the animal or person eats.
01:17:18.920 And there are obviously, you're aware of this, there are flavors of time-restricted feeding in
01:17:22.500 people where the window can be anywhere from 12 to 6, sometimes even more extreme than that. But you
01:17:27.540 limit the hours per day that the animal or the person eats. Intermittent fasting, I would put in
01:17:34.140 a 24-hour or more fast. That's a reasonable definition.
01:17:37.100 That's actually the definition I use. An intermittent fast is a fast that occurs at a frequency of greater
01:17:41.860 than once a day.
01:17:42.720 Right. Exactly. The other thing I would say, though, is that time-restricted feeding gets
01:17:46.280 even more complicated than that because there's evidence that it's not only about how big the
01:17:51.340 window is, but where in the day the window is. And that's actually one of the things that came out of
01:17:55.420 our review of the literature is there is this clear connection between how much we eat and when we eat
01:18:03.120 that ties into circadian rhythms. And that circadian biology, even since this review came out,
01:18:08.560 there have been papers that have come out that reemphasize the importance of when we eat and
01:18:15.080 what we eat. I don't think it's either. I think it's both that suggests that that's probably going
01:18:19.140 to be significant in terms of the consequences of the long-term health effects.
01:18:23.020 All right. I'm hoping I'm going to remember to come back to that, but let's keep going.
01:18:26.100 So then there's what people call fasting mimicking diets, which are diets that I've been engineered to
01:18:32.840 some extent to induce the same metabolic changes as caloric restriction, usually very low sugar,
01:18:38.240 relatively low protein, high fat, but also very low calorie. So that clearly goes in the bucket of
01:18:44.080 a flavor of caloric restriction. There's ketogenic diets is another one. And then there's protein
01:18:49.760 restriction.
01:18:50.620 So isocaloric protein restriction.
01:18:52.420 Well, both. So again, you really have to look, you have to take each paper one by one
01:18:55.920 and figure out, is it isocaloric or isn't it? And that's in some cases simply not possible
01:19:01.880 because the data is just not there, but you have to look closely. So there are examples of both.
01:19:06.420 I guess one way to think about it is, is it ad lib or not? In other words,
01:19:09.800 an ad lib ketogenic diet might end up restricting energy, but non-deliberately.
01:19:14.740 That's one way to think about it, but I don't know that that answers the question of whether the
01:19:18.480 benefit comes from caloric restriction or not, right? So that's a complication, but I agree with you.
01:19:22.480 That is, it's different. We don't think about this much in mice, but certainly in people,
01:19:27.260 it's true. If you are not ad lib, there are psychological consequences to not eating when
01:19:33.160 you want, to being hungry all the time. Good, bad, indifferent, but those have biological
01:19:37.560 consequences as well. So they are different. Absolutely.
01:19:40.980 Let's go back to the circadian one. I want to kind of get the insights there.
01:19:44.860 So first of all, let's talk about what you know in mice, and then let's figure out if there's
01:19:49.100 any extrapolation.
01:19:49.900 So when we wrote the paper, there wasn't much on this. I mean, people were thinking about it,
01:19:54.060 particularly in the context of time-restricted feeding, that there might be differences in
01:19:59.080 the window of time-restricted feeding for in humans, right? Early in the day, late in the day.
01:20:03.300 There's been a couple of papers that have come out since we wrote the review in mice that I think
01:20:08.220 make a pretty compelling case that the lifespan benefit from, say, a 30% caloric restriction diet
01:20:16.000 is a combination of when the animals are eating and how much they're eating. Most of the benefit
01:20:23.960 seems to come from the calories. So let's just say, this may not be exactly right, but I think
01:20:29.240 it's close. Let's just say that you get a 30% lifespan extension from 30% caloric restriction,
01:20:34.160 that the two-thirds of that benefit comes from the calories. But one-third of the benefit actually
01:20:39.700 comes from the fact that those mice eat all their food in a short window and are fasted essentially
01:20:45.340 the rest of that 24-hour period. And if you force them, and I say force because if you give a
01:20:50.420 calorically-restricted mouse its food, it's going to eat it right away. So if you force them to eat
01:20:54.980 little bits throughout the day, you lose a portion of that lifespan benefit, which is really interesting.
01:21:01.420 Now, a mouse eating in an hour and then going 23 hours without food, what would we even compare
01:21:09.020 that to in a human? I don't know. I really don't feel comfortable even speculating. So the first
01:21:13.340 simplistic approach would be to say, well, a mouse lives about three years, a human lives about-
01:21:18.140 I was thinking more of like, how long does a mouse take before it dies from starvation?
01:21:22.060 Yeah. So that's where I was going to go next. I think that length of lifespan is not the approach
01:21:25.840 you take when it comes to metabolism. So I would say that, and this is total back of the envelope
01:21:30.700 calculation. Maybe it's like a one to four ratio. So a one-day mouse fast might be a four or five-day
01:21:37.060 fast in people, but that's not even perfectly true because a mouse will go into ketosis relatively
01:21:43.300 quickly within 24 hours. And a human can go into ketosis that quickly.
01:21:47.860 Depending on their incoming diet.
01:21:48.840 Yeah, exactly. It's not a perfect equivalency, but maybe one to four or five. I hope I'm not
01:21:53.140 saying something totally stupid here, but I think that's probably pretty close. So again,
01:21:57.080 it's very different, potentially, these kinds of studies in mice. The other thing that I think
01:22:00.660 most people don't appreciate unless they've actually done these caloric restriction experiments is that
01:22:05.700 if you go back to the classic experiments of Rick Weindruck and Roy Walford, those mice are fed a
01:22:11.620 calorically restricted diet. They're also fed three times a week. So they are in fact-
01:22:16.020 It's insane. It's like they're basically doing a two-week fast between their meals.
01:22:20.300 Yeah. And so what you see, even in 24 hours in a fasted mouse, is you see pretty dramatic
01:22:24.700 reductions in organ size. The mice are being fed three times a week. They're going through this
01:22:29.260 reduction in organ size and then this really rapid hypertrophy. And you can see that decrease in
01:22:34.860 organ size and then rapid increase even on some of the fasting mimicking diet work that Walter Longo
01:22:39.880 has done.
01:22:40.280 Has anybody done their reverse experiment where you try to actually mimic the way humans eat and you
01:22:45.300 take two groups of mice and the controls are fed, whatever, 100% of the nutrient, but they're fed
01:22:52.360 every two hours over the course of the day. And the CR group are given 70% of that, but they're fed at
01:22:59.940 the same time intervals constantly throughout the day. In other words, you make it purely a calorie thing
01:23:04.380 and you really take out the fasting except when they're sleeping.
01:23:07.220 At least one of these two studies that I was referring to did that.
01:23:10.960 Oh, so that's how they were able to identify that two-thirds of the benefit came from the
01:23:14.820 reduction in calories and a third of it came from the additional fast.
01:23:19.540 Right, exactly. So, and in my mind, I think this is really important because this is one of the
01:23:24.540 points that we made in our review is if you look at the vast majority of the literature around
01:23:30.100 intermittent fasting and time-restricted feeding and fasting mimicking diets,
01:23:34.180 they're calorically restricted. So, there's a fasting period and a caloric restriction component.
01:23:41.080 And none of the prior studies really, really teased that out in a way that allowed us to
01:23:47.000 have an understanding of how much is calories and how much is fasting and maybe how much is
01:23:54.240 when you're fasted. That's still, I think, is an open question.
01:23:57.960 What else can we say about early feeding versus late feeding?
01:24:00.920 You mean early in life?
01:24:02.660 No, early in day versus late in day.
01:24:04.740 Yeah, I mean, this is an area I'll admit I'm not an expert in. So, I don't honestly
01:24:08.960 have an opinion about which is better. And again, this is where I think mice are not going to be
01:24:16.160 a good model for humans. Those studies need to be done in people.
01:24:20.080 Some have suggested that an early feeding window versus a late feeding window produces
01:24:25.220 better pairing of our insulin sensitivity to our nutrient arrival, right?
01:24:29.600 I think that makes sense. Most people would agree that particularly if you're eating something
01:24:34.960 that causes your blood sugar to spike, that doing that right before you go to bed,
01:24:38.380 probably suboptimal, right? So, I think that maybe that can explain most of that observation
01:24:43.880 that has been made that if you're going to do a time-restricted feeding, it might be better
01:24:47.160 earlier somewhere, at least not right before bedtime, I guess I would say.
01:24:51.000 These kinds of questions are really complicated in humans because you could ask,
01:24:55.800 what benefit are we looking at? So, if you're looking at overnight blood glucose levels,
01:25:01.960 it makes perfect sense. If you're looking at sleep quality, maybe it's going to be different
01:25:05.820 or maybe it's going to be different in different people. If you're looking at other biomarkers,
01:25:10.660 again, it could be different. So, in my mind, at least, maybe you have a different opinion on this.
01:25:14.940 In my mind, at least, it's not even really clear how we evaluate what is better and what is
01:25:20.900 suboptimal. It may depend on what your endpoint is, what you're actually interested in optimizing.
01:25:26.880 Clinically, we see in people who wear CGM that early feeding produces an overall lower
01:25:33.440 average glucose for sure because even if you get the same spike, like if you're doing the same meal
01:25:39.520 early in the day versus late in the day, there's something about how long it takes to come down at
01:25:44.240 night versus in the morning. Now, that could be you're more insulin sensitive in the morning and
01:25:48.320 therefore, it comes down quicker. It could be something to do with pairing sleep with the
01:25:52.400 nutrition that is tweaking this and that there's a feedback loop where the excess glucose creates a
01:25:58.320 little more cortisol. You get a little more hepatic glucose up, but I don't really know if that makes
01:26:01.860 sense. I mean, I've heard people argue that, but at the same time, you theoretically should have the
01:26:05.280 lowest cortisol at night anyway, so that really shouldn't be an issue. I don't really know what it is
01:26:09.080 other than just to say I've observed it empirically. You know, it generally doesn't produce a great
01:26:13.040 quality of sleep, but to me, this starts to get into – which I want to hear more about,
01:26:17.640 but this gets into the minutiae. At some point, you just got to focus more on other things, but
01:26:22.200 I want to go down this rabbit hole just for the sake of completeness.
01:26:25.160 Yeah, sure. To some extent, that's almost where we ended up. Let me give the big picture answer
01:26:29.880 for why I think this is important. So, I think these nutritional intervention studies in mice
01:26:35.560 are very powerful for dissecting the biological mechanisms that underlie the effects that they have,
01:26:43.260 and some of these diets clearly have effects on aging. I'm very, very hesitant to suggest that
01:26:50.660 people should adopt any of these diets based on the rodent literature where it's at today,
01:26:55.660 and I think there are a whole variety of reasons for that, but that's kind of where I ended up. I
01:26:59.620 think they're super useful for understanding the biology. I'm really not sure that they're going to
01:27:04.380 work the same way in humans. What did you learn about the protein restriction in the ketogenic diet
01:27:08.560 mechanistically in the mice? The ketogenic diet studies, there have really only been two that I'm
01:27:12.840 aware of that looked at lifespan and healthspan in mice. They were slightly different, but in mice,
01:27:18.600 you have to go to really, really low sugar to actually get the mice to go into ketosis.
01:27:23.700 Essentially, 1% or less carbohydrate diets. So, again, that's a difference from people.
01:27:29.560 One of the studies that fed a ketogenic diet lifelong saw no effect on lifespan, but they did an
01:27:34.500 intermittent ketogenic diet. I don't remember the exact protocol, but it was something like every
01:27:39.060 other day or maybe once every three days or something. And there, there was about, I think,
01:27:42.780 a 15% increase in lifespan. And I'm sorry, what did they do on the other days, the animals?
01:27:48.020 Regular diet. Oh, interesting. Wow. Yeah. So, it was just back and forth between the control diet and
01:27:51.880 the ketogenic diet. And that didn't result in caloric restriction? That's the thing. The mice were
01:27:55.920 calorically restricted. So, in some ways, it's an intermittent caloric restriction. And this is what I would
01:28:00.740 say. It's also interesting because the fasting mimicking diet papers are intermittent ketogenic
01:28:05.220 diets. Maybe that's one thing to agree on is that intermittent ketogenic diets in mice can increase
01:28:14.980 lifespan and seem to have benefits for healthspan. The effects aren't huge. That's the other take-home,
01:28:20.120 I would say, from our study. There are two nutritional interventions that relatively consistently give
01:28:25.680 big effects on lifespan. One is caloric restriction and one is protein restriction.
01:28:31.540 Caloric restriction, the most extreme study that I've seen is 65% restriction. And that gave about
01:28:38.720 a 65% increase in lifespan. So, these are big, big effect sizes. Wow. I wasn't aware of that.
01:28:44.740 Yeah. That's this Weindrich and Walford paper. And when did they start that and how long did that
01:28:48.800 restriction last? That's a good question. I don't remember. It was probably six or nine months. I think
01:28:53.740 most of their studies were early onset caloric restriction. This study was really interesting
01:28:59.260 because they did a graded response from 90%, 80%, 60%, 50%, 40% of ad lib. You get essentially a
01:29:09.800 graded response in lifespan and it's roughly linear. So, 90% animals?
01:29:14.920 No, but they didn't go that far. They didn't go beyond 60 or 65%. And I also think this is an
01:29:19.700 interesting study because I don't think you could do that study today because the animal care wouldn't
01:29:24.880 allow you. Yeah. This gets back to an element that we don't think about enough, which is what
01:29:28.900 do those mice feel like? Like think about how angry those mice would have been on a third of their
01:29:35.320 normal caloric intake. You know, again, I haven't done these kind of mouse caloric restriction studies
01:29:40.080 myself. I've obviously talked to a lot of people who did. I think to really appreciate that,
01:29:44.220 you've got to probably be in the animal room seeing them. Certainly activity goes up quite
01:29:50.320 dramatically. And that's one of the remarkable things about caloric restriction in mice is that
01:29:53.860 they are more active throughout life than ad lib fed mice are. And maybe it's a sort of foraging
01:30:00.280 response, evolutionarily selected foraging response, but they are definitely, you give them a running
01:30:04.240 wheel and they'll just run and run and run and run. Yeah. There are behavioral changes for sure in
01:30:09.820 mice that are calorically restricted. And this is actually one of my real concerns about caloric
01:30:15.360 restriction in people. First of all, we should be realistic and recognize you're never going to get
01:30:20.340 a significant fraction of the population to calorically restrict. It's hard enough to get
01:30:25.260 people to calorically restrict down to a healthy weight. To get them to go 30% beyond that, it's just
01:30:29.840 not going to happen. But of the people I know, I mean, being in this field, I know people who have done
01:30:36.220 every possible anti-aging intervention you could imagine. And of the people I know, and I know a lot
01:30:41.820 of people who've dabbled in various forms of caloric restriction, certainly true caloric restriction has
01:30:47.080 real psychological consequences. And I really would be concerned. I have been concerned for some of the
01:30:54.080 people I know who've done this. If we started trying to do this in the general public, there's social
01:30:58.960 isolation that you get when you're calorically restricting, but then there's the biological changes in
01:31:03.980 the brain and you're hungry all the time. We often don't appreciate those aspects of some of these
01:31:09.560 nutritional interventions. But in the mice, it's hard to know what their psychological consequences
01:31:14.260 are. And what do we know about caloric restriction later in life in the mice versus earlier? The sort
01:31:19.240 of traditional thinking is you have a window in which you can do it early and beyond that, it's not
01:31:24.080 as effective. I think we're going to talk about some data that counter that. And then of course,
01:31:27.620 you have the NIA experiment we talked about earlier. In the monkeys. In the monkeys, where the early
01:31:32.780 fast didn't improve longevity, the late fast appears to have, although that was sort of a
01:31:38.520 subgroup analysis. Hard to draw causation there. What I would say about the mice is that for a long
01:31:43.680 time, the dogma was that caloric restriction didn't work if you started it past, I don't know,
01:31:49.140 15 months of age, which is maybe the mouse equivalent of a 40, 50-year-old person. So most of the early
01:31:54.920 caloric restriction studies were done, like I said, starting sometimes pre-development. The early rat
01:32:00.320 studies were pre-development and then sometimes, you know, six, nine months of age. When I first
01:32:04.720 started in the field, that's kind of what I was told. Like this is a settled question. More recent
01:32:09.320 studies that have been done in some ways more carefully, different diets, certainly. If you do
01:32:14.560 a graded onset of caloric restriction, in other words, don't go right from ad lib to 40% restriction
01:32:20.620 the next day. If you do sort of a graded onset, you can get lifespan benefits from caloric restriction
01:32:26.800 20, 22 months of age. So whether it's as good as starting early, I think the consensus is still
01:32:34.740 that the answer is no. You're never going to get the same magnitude of benefit from caloric restriction
01:32:41.080 starting late as you do starting early. But that could be wrong. So I would say that's the consensus,
01:32:46.880 but I don't think we know for sure whether it's possible if you did it just right, that you could get
01:32:52.700 most or all of the benefits from starting late in life. So Matt, on this topic of CR in mice,
01:32:58.400 again, the dogma has generally been, and I've been victim of this just blindly assuming it to be the
01:33:03.700 case, that CR in mice only works early in life. How applicable is that to humans? I don't know.
01:33:09.700 But a listener of the podcast actually pointed out that, in fact, there are some data that try to get
01:33:14.180 at this question. So there's this Han study 2019, which we'll link to, that looked at 800 female
01:33:20.540 mice. Now, this is a pretty elegant experiment. So for the first three months, they ran these mice
01:33:25.500 out on an ad libitum diet. And then at three months, they were split, randomized to, I believe,
01:33:31.600 a 40% calorie restriction versus ad lib. They ran that out until 24 months. And then each of those
01:33:38.400 groups was further split ad lib versus continued on. So you had one group that was, everybody's the
01:33:44.520 same until three months, one group that spent the rest of their life on dietary restriction,
01:33:48.020 one group that spent the rest of their life ad lib, and then you had the middle groups.
01:33:52.980 21 months, calorie restricted, then to ad lib, 21 months ad lib to then calorie restricted.
01:33:58.400 Okay. So the ends of this were not interesting, meaning the ad lib group lived the shortest.
01:34:03.560 We were looking at the figure earlier today, 1,200 days, roughly.
01:34:06.920 Maximum lifespan.
01:34:07.700 Yeah. Maximum lifespan. That's right. Median lifespan would have been,
01:34:10.780 looking at the graph, about 900 days.
01:34:12.360 Which is pretty good.
01:34:13.020 Yeah. So I was going to say, how does that stack up with what we talked about on the last podcast
01:34:16.900 about length of life of control?
01:34:18.660 That's a reasonable lifespan for control. I think if I remember correctly, this was also done not
01:34:22.640 in C57 Black 6, but in a little bit longer lived hybrid strength.
01:34:26.100 That's right. F1 hybrid.
01:34:27.180 So it's reasonable lifespan.
01:34:28.500 Okay. Looking at the all CR all day, mice looks like they had a maximum lifespan of just below,
01:34:35.900 call it 1,400 and change, with a median that I'm going to say was about 1,150.
01:34:40.980 Good lifespan extension.
01:34:41.820 Okay. So now what's interesting is the middle groups, which is really true. So I'm going to
01:34:45.820 just give you my little iPad so you can look at that table, which will link to this.
01:34:48.480 Okay. I got it right here.
01:34:49.320 You got it right here?
01:34:50.540 I remember the take-home message.
01:34:51.720 You do. Okay. Yeah, yeah, yeah. So what happened to the two middle groups?
01:34:54.760 One thing I would say is I think this is a pretty early onset of CR.
01:34:58.320 It really is. Three months.
01:34:59.620 Yeah. This gets back to what I was talking about before, that it seems likely from the early studies
01:35:04.300 that were done in rats, where they got some of these really, really large effects,
01:35:06.920 that some of the benefits of CR come from actually being restricted during development itself.
01:35:12.380 So I think that's useful to put into context. So then the big question here is what happens
01:35:16.580 if you start caloric restriction late in life? Or what this study did that I'm not really aware
01:35:21.960 of anybody doing previously is kind of the flip. It's almost like a crossover.
01:35:25.780 That's right. Yeah, it totally is.
01:35:26.820 So in this case, when they started CR late in life, there is a significant but not huge effect.
01:35:33.540 Like the magnitude of the lifespan extension is much less than in the mice that were on
01:35:39.320 CR from three months of age. That makes sense. That fits with what else is in the literature.
01:35:45.120 There were earlier studies. I think Steve Spindler did one, not too many years, maybe four or five
01:35:49.520 years before this one that did sort of a similar sort of approach starting around 15 months of age.
01:35:54.120 They saw a significant but not as large benefit from starting late in life. So that seems to be
01:36:00.260 the consensus. The thing that's really interesting here is, you know, what happens if you're CR'd for
01:36:06.140 an earlier period in life, and then back on AL? Do you lose the benefit? And it seems like the answer
01:36:13.040 is no. Those animals actually were longer lived than the mice that went on CR late in life. You could
01:36:19.960 ask some questions about, is it about the total amount of your life that you're restricted? Is it
01:36:25.360 about when you go on and when you come off? And I think in mice, this is still an open question. We
01:36:30.360 don't really know what the mechanisms are. Although the early in life mice had a longer median. The
01:36:38.260 median life expectancy was- The ones that were on CR and then switched to ad libitum. Yes, that's right.
01:36:42.740 They lived a little bit longer, but the bigger difference was the median life expectancy was higher
01:36:47.760 than the flip. Yes. Although I think we have a little bit difference in definitions. I tend to
01:36:52.160 think first about median. You seem to think first about maximum. But yeah, I mean, I think what you're
01:36:56.100 saying is right. The median lifespan is quite different between those two groups. It is the
01:37:01.440 difference. The maximum is very trivial. That's right. The real question here is, well, aside from
01:37:07.020 what does this mean for humans, which I would say we can't draw too many conclusions from humans from
01:37:11.160 this, but what is the underlying mechanism? And is it really just about the total amount of time that
01:37:16.220 you've been on CR? Or is it an interaction with how old you are, the developmental process,
01:37:22.360 and then what happens at the end of life, which is mostly the degenerative process and when you go on
01:37:27.440 CR? One thing that's worth adding to this too, is it's an interesting comparison to what we know
01:37:32.580 about mTOR and rapamycin. So with rapamycin, the data are pretty clear that you can start rapamycin
01:37:39.180 certainly well into middle age and maybe even into very old age and get most of the benefit. So
01:37:45.700 if you compare the curve here where they started the mice on CR at 22 or 24 months, whatever it is,
01:37:51.000 the effect is pretty small compared to CR. With rapamycin, you get almost exactly the same
01:37:56.360 benefit starting at 20, 22, 24 months as you do starting early in life. So that might tell us
01:38:02.840 that there's a difference, right? There clearly is a difference.
01:38:05.340 There's a different mechanism potentially as well. It could be that rapa is doing something different,
01:38:08.980 or it's a different dose effect relative to it.
01:38:11.340 Exactly. So it's an open question exactly why it's different, but it seems to be different.
01:38:16.160 Yeah, I'm really glad you brought that up because we talked about that with Rich Miller on his
01:38:19.480 podcast, which was a fortuitous accident, basically because they couldn't get the formulation of
01:38:25.340 rapamycin in that first ITP study.
01:38:27.540 One of my favorite stories in science, yeah.
01:38:29.320 Yeah, tell people that story.
01:38:30.320 So take a step back. The NIA started this program called the Interventions Testing Program. It must
01:38:36.980 have been the early 90s. And the idea here was, maybe it was early 2000s, sorry. Dating myself
01:38:41.600 again, losing my decade. So early 2000s. And the idea here was, I think, really smart. The idea was
01:38:47.660 that we could create a tool where the scientific community could nominate interventions for lifespan
01:38:55.360 testing in mice. And it was set up so that it would be done in triplicate, three sites. There still are
01:39:00.040 three sites for the ITP. So anybody in the community can nominate any intervention. There's a selection
01:39:06.440 committee that selects them every year. And if an intervention is selected, then the Intervention
01:39:11.280 Testing Program sites start the cohorts of mice on that intervention, you know, in whatever year it
01:39:17.100 was selected for. So sometime back in the early 2000s, Dave Sharp nominated rapamycin. Some ways he was
01:39:23.780 ahead of his time because I think when he nominated rapamycin, it was even before the first
01:39:28.640 invertebrate studies on mTOR and rapamycin. It was right around the same time they were being
01:39:32.320 published. So he, I think, was thinking about it from a cancer perspective primarily. In any case,
01:39:38.220 he nominated rapamycin. It got selected. It went into the cohort. And they typically test five or six
01:39:45.680 interventions or drugs each year. So they have a huge number of animals at each of these three sites
01:39:51.380 that are destined for these interventions to be tested in. And rapamycin was one of them.
01:39:56.380 Randy Strong, who's one of the PIs on the ITP, who's also got a strong biochemistry background,
01:40:02.260 I think recognized pretty quickly that the rapamycin wasn't stable in the food.
01:40:06.680 We could actually come back to this if you want to, because this is relevant for people as well.
01:40:09.960 So, and it gets broken down in the pH of the gut. So basically if they just put the powder in the
01:40:15.700 food, there's no bioavailability. It doesn't get taken up by the mice. And so they recognized that
01:40:20.640 right when they were supposed to start the experiment. And, you know, of course they were like,
01:40:24.700 crap, what do we do? We could just not test rapamycin. And I don't know if it was Randy or
01:40:29.600 who. Somebody said, well, I think I can figure out a way to stabilize the rapamycin, put it in the
01:40:35.460 food so that we can give it to the mice and we can do the lifespan experiment. I think what they
01:40:39.040 didn't recognize was that it was going to take 18 months or so to figure this out. So once they
01:40:43.900 finally developed what they call E-RAPA, encapsulated rapamycin, it's basically designed
01:40:49.120 so that it won't break down in the gastric pH. Once they developed that, they were now 18 months
01:40:54.180 into this lifespan experiment. Before this, I think everybody, myself included in the field, thought
01:40:58.900 you had to start early in life or you weren't going to get much of a benefit. There was really
01:41:02.660 almost no chance a drug was going to increase lifespan starting that late in life. But fortunately,
01:41:08.040 they went ahead with the experiment starting at 20 months of age. And what they found was that they
01:41:14.740 got this robust lifespan extension from starting with rapamycin treatment at 20 months of age.
01:41:19.920 And just to give some context, that's about the mouse equivalent of a 60 or 65-year-old person.
01:41:25.720 And I love the experiment. I love the outcome, obviously, because first of all, nobody thought
01:41:30.500 it was going to work except maybe Rich Miller. I'll give Rich credit. Maybe he thought it was going
01:41:34.400 to work. And it was really the first time anybody had convincingly shown that you could start
01:41:39.760 intervention in middle age in a mouse and get robust lifespan extension. And for me,
01:41:47.020 honestly, I reviewed that paper. And when I first time I saw that result, I'm like, this changes
01:41:51.200 everything. We actually have a chance for translational geroscience because you might be
01:41:56.120 able to intervene late in the aging process and have significant impact. That was 2009 when that paper
01:42:01.700 came out. So in the 13 years since then, the whole paradigm in the field has changed. Most people who
01:42:06.860 are studying interventions today are studying things that they test for efficacy late in life
01:42:13.240 because that's what we need to do in people. So it was a super important result for the field for that
01:42:18.600 reason. And it all came about by an accident. Nobody would have designed that study that way
01:42:23.260 beforehand.
01:42:24.980 Now, you were going to make a point about the bioavailability around.
01:42:27.780 So this is something that's only recently come across my radar, but I've heard several results now that
01:42:32.280 convinced me that it's true. So, you know, I mentioned the reason why they had to make this
01:42:36.840 E-Rapa is because rapamycin isn't stable at the gastric pH of mice. Same thing seems to be true
01:42:42.160 in people. So there are people who are getting their rapamycin from the rapimmune, which is the
01:42:47.180 brand name generic or the brand name serolimus comes in these triangle-shaped pills. There are also
01:42:52.220 people who are getting it from compounding pharmacies. And I've heard of several cases now
01:42:56.060 where the bioavailability is much lower in the compounded rapamycin in a capsule than in the
01:43:03.380 actual rapamycin.
01:43:04.160 The triangle, the white and yellow triangle.
01:43:06.640 Exactly. So it's just something for people to be aware of. And I don't think most physicians are
01:43:10.600 aware of it. I don't think most compounding pharmacies are aware of it. We've never had
01:43:14.140 it compounded. So we've only prescribed serolimus or rapamycin. You know, it's not a cheap drug. So I
01:43:19.800 can understand why there's a desire to compound it because it's, I don't know, it's got to be like
01:43:23.760 five, six bucks a milligram.
01:43:25.260 Yeah, I think that's about right.
01:43:26.620 That's very interesting. Yeah. So Matt, obviously one of the other things that came out of that review
01:43:30.520 article in the animal stuff was, as you said, the protein restriction. And I think of all the
01:43:36.680 topics in nutrition, this is the one I'm most interested in. I really don't care that much
01:43:41.680 about fat and carbs. Don't tell anybody, but I care an awful lot about protein. You know, in fact,
01:43:46.400 when you came over today, you probably saw me chasing down what was left of a protein shake. And
01:43:51.000 I think I was mentioning to you or to my wife, that's the only part of nutrition that is kind of,
01:43:56.440 I don't want to say a chore, but it's a very deliberate part of how I go about the day,
01:44:01.320 which is I really have to think about it. And the reason is I'm trying to eat a gram of protein
01:44:06.900 per pound of body weight spread out into four buckets. There's reasonable evidence to suggest
01:44:13.220 that if you consume too much protein in one sitting, and it's typically more than about 0.25
01:44:18.880 grams per pound is the general thinking, you're going to end up oxidizing some of that protein.
01:44:24.720 So it's not that it's harmful. It's just that you're not getting the amino acids you need for
01:44:29.620 muscle protein synthesis, which is of course our objective. So that means I'm kind of walking
01:44:33.840 around trying to get 40 grams here, 40 grams there, 40 grams here, 40 grams there. And truthfully,
01:44:39.600 that's not trivial if you're not willing to consume a whole bunch of crap with it,
01:44:44.660 if you're really just trying to focus on the protein quality. So look, the RDA says I'm crazy.
01:44:49.580 The recommended daily allowance of protein is 0.8 grams per kilogram, which is less than half
01:44:57.440 of what I would consume. And by the way, it's not just that I'm making up the amount that I'm
01:45:01.140 consuming. I'm doing it on the basis of other data that suggests that this is the amount of
01:45:05.000 protein consumption you need for optimal muscle protein synthesis. So where does this disconnect?
01:45:10.120 First of all, we can talk about the rodent studies, which is in the biology of aging. I think
01:45:14.860 the RDA question, that's a different question. It's my understanding that that actually was
01:45:20.040 developed to be protein balance for 95% of the population when sedentary. What that means,
01:45:28.360 first of all, that's a minimum amount, not necessarily the optimal amount. And it probably
01:45:32.700 very much depends on lifestyle. And lean body mass to begin with, even though it's sort of normalized to
01:45:38.720 it. And the reason why I bring this up is I think there's a lot, again, a lot of confusion
01:45:42.200 among the general public about what the RDA means. And it's not necessarily a bad thing to
01:45:47.740 be above the RDA in some areas, maybe a lot of areas. So I think that's just worth expanding on
01:45:52.540 just a little bit. I sort of jokingly think of the RDA for protein as what you need to
01:45:56.200 not waste away and wither up and die. Right. So you're not losing muscle mass.
01:46:00.680 So then the question of what is the relationship between protein and aging, I think is a really
01:46:04.980 important one. And it's gotten a lot of attention in the field. And like I think a lot of other
01:46:09.660 things, there's a lack of clarity about what we actually know and what we should be recommending
01:46:14.220 to people. So let's take a step back and start with the animal studies, the mouse studies.
01:46:19.320 I think there it's pretty clear that you can extend lifespan through protein restriction.
01:46:26.220 And there are actually a couple of flavors of protein restriction. You can restrict all protein
01:46:31.080 down to some percentage, some low percentage, or you can restrict specific amino acids, particularly
01:46:36.700 branch chains, tryptophan, methionine, or branch chain amino acids are the ones that have been
01:46:41.780 studied. And again, I make that distinction because it's not really clear that the mechanisms are the
01:46:47.200 same across these different flavors of protein restriction. The common mechanism that does seem
01:46:53.660 to potentially underlie all of these forms of protein restriction is inhibition of mTOR. And again,
01:46:59.140 that's partly why this becomes complicated, especially when we start talking about extrapolation to
01:47:03.440 human. You and I both recognize that inhibition of mTOR can have beneficial effects in the context of
01:47:10.620 aging and healthspan, certainly in mice, almost certainly in people, I would say. And protein is
01:47:15.800 an activator of mTOR. And we know a fair amount about the biochemistry of that, that particularly
01:47:20.620 branch chain amino acids can directly activate mTOR through cestrins, and that's sort of all worked out.
01:47:27.740 And so it seems intuitive that protein restriction would be beneficial by turning down mTOR. It seems
01:47:33.660 counterintuitive that what you were just talking about would be beneficial because you might be
01:47:37.780 hyperactivating mTOR. So we can dive into that. That's the simplest possible mechanism I can think
01:47:42.980 of for why protein restriction, especially branch chain amino acid restriction, would be having an impact
01:47:50.380 on lifespan and healthspan in mice. The other player that seems to be important, particularly in
01:47:56.020 total protein restriction, is a protein called FGF21, fibroblast growth factor 21, that is secreted in
01:48:04.780 response to a low-protein diet and then has effects on liver metabolism and also inhibition of mTOR
01:48:11.960 reduction of IGF-1. So that seems to be required for the lifespan extension that is seen from protein
01:48:18.360 restriction in mice, potentially partially upstream of mTOR and liver metabolism. The interesting thing
01:48:24.600 there is FGF21 overexpression by itself has also been reported to be sufficient to extend lifespan in
01:48:31.620 mice. So it kind of fits that that could be part of the story. So the question, one question is, is
01:48:37.660 protein restriction always beneficial in mice and can we separate it from caloric restriction? This is where
01:48:44.420 you really have to look closely at the studies and determine, did the mice on protein restriction
01:48:49.740 eat less, eat the same amount, and eat more? And it's interesting because you can actually find
01:48:54.580 examples of all of those. And honestly, I don't really understand why that's the case, except it's
01:48:59.000 something about the different compositions of the diet. What does seem to be the case is that when you
01:49:04.000 restrict for certain amino acids, if you're deficient for methionine, for example, or tryptophan, the mice
01:49:10.760 absolutely will eat more and they don't gain weight and they do seem to live a little bit longer.
01:49:15.120 So that could be a somewhat distinct mechanism there that we don't really understand.
01:49:20.340 What was the most compelling evidence you saw when you tried to tease apart
01:49:24.220 the relationship between protein and total intake?
01:49:27.540 I think the branched chain amino acid and methionine restriction studies are pretty clear
01:49:32.100 that those animals are consuming more calories than certainly if you matched a weight than the
01:49:38.340 ad libitum mice and they're living longer.
01:49:40.500 And what do we think is the route or mechanism through which methionine exerts this effect?
01:49:45.680 That's still really being worked out. There are lots of mechanisms that have been proposed. I
01:49:49.440 suspect mTOR plays a role. Methylation, methyl donors are important for a bunch of different
01:49:54.940 epigenetic modifications. So there may be a role there going back to the epigenome that we talked
01:49:59.500 about. Methionine is the first amino acid in every protein. So there could be effects on protein
01:50:04.860 synthesis. There's evidence linking methionine restriction to sulfur amino acid. Biology,
01:50:10.280 which has been implicated in aging. So it's hard to know, and maybe it's not one thing.
01:50:14.960 And those all sound like potentially just a substrate reduction problem, right? Like
01:50:18.520 less sulfur cross-bridging, less protein synthesis.
01:50:22.100 You know, if you look back in the literature in the invertebrate, inhibition of protein synthesis
01:50:26.440 in some cases is enough to extend lifespan. And of course, mTOR is a primary regulator of protein
01:50:32.660 synthesis. So when you inhibit mTOR, you can also inhibit protein synthesis. That's part of the
01:50:37.820 challenge here is this network is so interconnected that when you tweak one part of it, you have
01:50:42.760 effects throughout the network. And it's really hard to know which of those effects are causal.
01:50:47.180 So let's talk about time course. When you consume a protein-rich meal, do we have a sense of how long
01:50:53.620 mTOR is being activated in response to that set of amino acids?
01:50:58.560 I'm sure somebody does. I don't know the answer to that. Almost certainly, it's going to depend on
01:51:05.380 what you eat in combination with the protein, when you eat, how active you are.
01:51:10.340 I remember talking to David Sabatini about this through the lens of BCAA drinks. If you're going
01:51:16.240 to pound branched-chain amino acids during a workout because you want as much anabolic signal as
01:51:22.320 possible. And this is a couple of years ago, so maybe things have changed. But based on that
01:51:26.720 work, I think Bobby Sutton had done the work in his lab, if I'm getting his name right, was it Bobby
01:51:30.920 Sutton was the guy who did that science paper that looked at the leucine sensor on mTOR?
01:51:35.920 The answer was it didn't stay on long at all. Free amino acids were so short in their ability to turn
01:51:43.900 on mTOR that unless you had an intravenous drip of this stuff, it was going to be very difficult. So much
01:51:50.680 so that the idea of using BCAA analogs to treat sarcopenia was going to require drugs that could
01:51:58.940 stay on much longer. Is that kind of within your frame of thinking?
01:52:03.080 I think so. And I think it also makes sense in a biological context. I mean, cells and tissues,
01:52:09.080 you know, again, this gets back to the whole homeostasis concept. Cells and tissues have evolved
01:52:14.100 to maintain metabolites, and amino acids are metabolites, right? They're involved in many
01:52:18.220 different metabolic reactions within certain levels. And there are all sorts of mechanisms
01:52:22.580 to ensure that if a metabolite gets outside of that range, that we soak it up, we do something
01:52:28.940 else with it. So I think it makes sense that you're probably not going to have a persistent increase
01:52:35.400 in branched-chain amino acids far outside the normal range. What I would say, though, is that slightly
01:52:40.880 elevated branched-chain amino acids chronically can have big effects on the sort of downstream
01:52:47.240 processes. And there are some inborn diseases of childhood where you have elevated levels of
01:52:51.940 branched-chain amino acids. We know that there are consequences to even having somewhat modest
01:52:57.740 increases in mTOR, hyperactivation of mTOR signaling chronically. So again, I think the context really
01:53:03.940 matters. But yes, it's my intuition that it's probably hard to get very large, persistent increases
01:53:12.040 in mTOR simply from taking a branched-chain amino acid supplement. It doesn't mean it couldn't have
01:53:17.900 some effect on muscle building right after a workout, but I suspect it's hard to have long-term
01:53:23.360 persistent effects on mTOR.
01:53:24.540 I mean, the anabolic data suggests it's not necessary. It's just, again, muscle protein synthesis
01:53:29.540 window is open long enough that simply delivering a great source of whey protein in the hours after a
01:53:37.060 workout seems sufficient to not restrict muscle potential growth.
01:53:41.300 I think the other thing, though, that is also important to appreciate, and this is true with
01:53:45.220 rapamycin as well, I think a lot of people get confused about this, is it's not only about
01:53:49.100 how high mTOR gets turned on or how low it gets turned down, it's also about where that happens.
01:53:56.840 People for a long time thought that rapamycin would cause muscle loss. We don't see that. I mean,
01:54:03.160 we just don't see it in mice, and we don't see it in people, and I think it's probably because
01:54:07.360 I'm guessing you're not seeing it in dogs.
01:54:09.240 We have not seen anything to suggest that in dogs, yeah. I'm guessing that has as much to do
01:54:13.800 with how much, maybe more to do with where mTOR is being affected than how much we're inhibiting mTOR
01:54:19.360 or when we're inhibiting mTOR, and so I think the same thing is probably...
01:54:21.740 And do we know where the selectivity of rapamycin is? I mean, is it more selective in
01:54:25.560 hepatocytes? Is it more selective in adipose tissue? I mean...
01:54:29.500 I don't know of any good studies that have really carefully looked at this. There have
01:54:33.840 been a few studies in mice that tried to look at tissue mTOR signaling in the context of rapamycin.
01:54:39.640 It's a very technically challenging problem.
01:54:41.560 Well, and this is what I was just going to say. It gets even more complicated because
01:54:44.720 even in a mouse, where you can essentially control almost everything, what the mice are eating
01:54:49.780 and when they last ate has, if anything, as big, maybe bigger effect on mTOR signaling than rapamycin.
01:54:57.540 There have been, like I said, a couple studies that looked at this, and I'm not sure...
01:55:00.400 And they got different answers, and I'm not sure who to believe because I don't think either was
01:55:04.240 wrong. The only way I could imagine doing this is you have to be able to do subtractive studies
01:55:08.180 where you have to be able to do it in the context of a whole bunch of different diets first,
01:55:12.060 get kind of a baseline that you then pull out of potentially what you're seeing. But I mean,
01:55:16.240 it gets... It's complicated. And again, that's why I often will gravitate back towards
01:55:21.060 what are the functional consequences we can actually measure? Sure, I get it. You think that treating a
01:55:26.900 mouse with rapamycin is going to cause sarcopenia? Let's do the experiment and find out. The answer
01:55:31.060 is no. It doesn't. Right? So that tells us it's at least not as simple as we thought it was going to
01:55:35.340 be. Now, what about the flip side of that is more protein versus less protein activating mTOR in a way
01:55:42.240 that is counterproductive? I think it can. I think there are probably certainly cases where it can.
01:55:47.900 I don't know that anybody has really carefully done that study in mice. There was a study... It's a
01:55:53.120 really interesting study by Steve Simpson and colleagues where they did this nutritional geometry
01:55:57.820 work where they basically looked at different compositions of carbohydrates, fats, and proteins.
01:56:03.160 In Australia? Yeah, exactly. And, you know, looked at... I don't remember how many diets. There's a whole
01:56:07.660 range of diets, different compositions of the three macronutrients. Tried to control for caloric intake,
01:56:12.780 which is hard, as you can imagine, but I think they did a pretty good job. And then asked, what does it look
01:56:17.440 like in terms of metabolism, energy expenditure, lifespan? So the lifespan studies, I think, are pretty clear
01:56:23.200 that most of the diets where the mice lived the longest were towards the low end in protein. But there
01:56:30.820 were some things that I think called into question exactly what was going on there, because it wasn't the
01:56:36.340 case that the mice that were energetic, the diets that were energetically lowest gave the longest lifespan,
01:56:41.940 as you might expect from caloric restriction. And the diet that actually gave the absolute
01:56:46.240 longest lifespan had like, I don't know, it's like a 40% protein in it. So the way I interpret that is
01:56:51.240 that there are many ways to get to longevity. And how calorie restricted was that? They were not
01:56:56.660 calorically restricted at all. So you're saying that a diet that was ad lib with 40% protein had the best
01:57:02.800 outcome? The best absolute lifespan, yes. How do we even reconcile this body of literature? My view is
01:57:09.300 there are probably multiple paths to longevity. And we really don't understand the inner relationships
01:57:16.940 of these macronutrients in the diet with enough sophistication to get beyond sort of broad, general
01:57:24.040 predictions. And again, this is an area where I believe, like I can't prove it, but my intuition from
01:57:30.200 the data that I've seen and just my observations of people is that in humans, this relationship between
01:57:36.440 protein and health during aging is probably very different than it is in mice. I think mice are
01:57:42.260 able to tolerate a very low protein diet without some of the consequences that we see in people.
01:57:48.380 That's my intuition. I don't know that that's true, but that's my intuition.
01:57:51.340 I mean, it's my intuition well as well, because clinically what we see in what I call the death
01:57:57.940 bars, the death bars is our internal nomenclature for how people die. We just constantly look at death
01:58:03.220 bars and we double click and double click and double click all the way to try to tease out
01:58:07.480 everything that is reducing lifespan and health span. And the problems that occur in humans when
01:58:13.960 they are under muscled are insane. And it ranges from the metabolic consequences of being under muscled.
01:58:21.360 Our muscles are a sink for glucose. They are the single most important sink we have for glucose
01:58:28.400 and our ability to tolerate glucose and maintain glucose homeostasis in the presence of larger,
01:58:34.560 more metabolically healthy muscles is the difference between having diabetes and not having diabetes.
01:58:39.960 Furthermore, when you think about sarcopenia and when you think about osteoporosis, which again,
01:58:46.240 I just don't think we're talking about how these things impact animals. Like we don't study any animal,
01:58:51.140 including primates in a setting where sarcopenia and osteoporosis are problematic.
01:58:55.740 And yet I would ask anyone to consider the entire population that they know over the age of 75.
01:59:03.780 And I would ask you take every person that is alive today that's over 75 and tell me how many of them
01:59:10.380 are not suffering at least some consequence of one or both of those phenomenon. And if somebody did that
01:59:17.100 analysis, I would be shocked if we didn't find at least 80% of people over the age of 75 are
01:59:24.300 experiencing this. And if you look at the activity, just monitor the activity level. Once they hit 75,
01:59:30.640 they fall off a cliff. So muscle mass dramatically plummets, activity levels dramatically plummet,
01:59:36.500 difficult to say which one's feeding which, but there's no question that something is happening
01:59:41.140 to our species at about the age of 75 that is a structural problem. And none of this other stuff
01:59:47.200 matters if that sucks. I don't care if I live to 100 and don't have cancer if I'm an invalid for the
01:59:55.140 last 25 years and I can't play with my grandkids and throw a ball. For me personally, I'm not saying
02:00:01.440 that's a, that's not a view that everyone should take in the world. I'm just telling you that's my
02:00:04.860 view. I mean, I think that's absolutely correct. I guess the question, and I think this is still where
02:00:09.920 some of the confusion comes from, is how important is dietary protein in that maintenance of muscle
02:00:16.680 or loss of muscle in people who are going to go the wrong direction? I think the data is that it is
02:00:21.880 quite important. There are lots of studies that have compared the RDA versus the double RDA standard,
02:00:29.660 and it's a significant difference. Protein makes a very big difference following, obviously,
02:00:36.280 the training that is necessary to stimulate muscle protein synthesis. So I think those have to be
02:00:40.920 coupled to some extent. Absolutely. I believe there are data, and I hate when I have to say
02:00:45.640 this because I just, I'm going to say something and it's going to be wrong and 20 people are going
02:00:49.180 to respond. It's okay, I do it all the time. Don't worry about it. In anticipation of the fact that
02:00:52.220 there are data that I've read and I don't have the memory I once had, I believe there are data that
02:00:57.120 show just the protein difference alone can make some difference, but it's not nearly the difference you
02:01:02.960 get when you pair it with hypertrophy training. That's my recollection as well.
02:01:06.640 Which brings us to the interesting question then, why is it that there is a camp? And in my field,
02:01:13.260 it's a pretty vocal camp in the aging field that would argue that low protein is the best
02:01:20.600 nutritional strategy for aging and health span in people. And this gets back to the point I kind of
02:01:28.660 started with, which is that you can find the answer you want for almost any question in this area that
02:01:34.420 intersects in nutrition and aging. There will be a study that will fit your belief. So I think you
02:01:39.340 really have to be careful, or I try at least, to take a global view and try to understand what is
02:01:44.680 the totality of the data say. But there are epidemiological studies and one in the field
02:01:50.720 most people will point to when they go to humans and they talk about low protein. The study that Walter
02:01:56.760 Longo was the senior author on and Morgan Levine was the first author on where they looked at
02:02:01.500 protein consumption and all-cause mortality as a function of age in people. There were some
02:02:08.220 studies in, I think they had some yeast studies in there as well, maybe some cell culture studies.
02:02:12.220 The take-home message was that low protein is beneficial up to about 65 years of age. And
02:02:20.000 then once you get above 65 years of age, it kind of flips and people who ate a higher protein diet
02:02:25.560 have lower all-cause mortality. I should be clear, when I say beneficial, we're talking specifically
02:02:30.100 about all-cause mortality. Which at the end of the day is a very important metric.
02:02:36.020 Sure, you want to be alive.
02:02:37.040 Yeah, it's not the most important metric necessarily. You could argue it's equally important to the health
02:02:41.900 span metrics. Okay, so let's make sure people understand what that means. That means below
02:02:46.260 the age of 65, the epidemiologic data in this study suggested people eating less protein had
02:02:53.040 lower mortality in all-cause mortality. And above 65, you saw that reverse.
02:02:57.520 That's right.
02:02:58.000 Now, did that paper make any attempt to quantify the net impact on mortality? Because the very
02:03:03.720 misleading thing about an assessment like that is when you look at mortality adjusted by population
02:03:10.380 before the age of 65, it's relatively low. Above the age of 65, it goes up very non-linearly.
02:03:19.640 So when we do our death bar analysis, it's like, this is the death per 100,000 people.
02:03:26.740 If you're 40, 50, 60, 70, 80, 90, like, you know what I mean? It just becomes insane.
02:03:33.120 So you could argue through that analysis, you're much better off with a high-protein strategy,
02:03:38.940 even if it's throughout life, because the absolute reduction in mortality would unquestionably be
02:03:44.420 lower as a result of the benefit you would have later in life.
02:03:48.700 I absolutely agree conceptually with what you said. The impact of a change in mortality late in life is
02:03:54.060 going to usually swamp the impact, certainly swamp the same impact on mortality early in life.
02:03:59.660 I think the question here is, what are the relative effects? They did model this a little
02:04:05.220 bit, and it is in their model. I couldn't get the data. I can't evaluate exactly what they did.
02:04:11.400 But in their model, the relative risk crossed somewhere in the 60s, right? In other words,
02:04:18.540 your total mortality benefit was lower eating a high-protein diet. I think it was starting
02:04:25.000 somewhere in the 60s. And that actually surprised me, because for exactly the reason you said,
02:04:29.020 the relative impact of the high-protein diet early in life would have to be an order of magnitude
02:04:35.100 greater than the relative impact of the... So I'm sorry, say what they're finding was again
02:04:39.280 at the age of 60? I don't remember the exact number. It's in the paper. You can see the curves
02:04:43.180 crossed. It was much later than I thought it would be, given that 65 was the point that they kind of
02:04:47.340 pick. So I would have thought maybe in your 50s. So I actually tried to do my own modeling of this
02:04:52.220 off of the data that I could find on relative risk for low and high-protein. Again, what you define
02:04:58.000 low, what you define high, you know, they're... And you're trying to ask the question, when should
02:05:01.880 you switch the diet? Or maybe more formally, at what age does the risk equal out? Yeah, what's the
02:05:07.560 crossover? Yeah. And what did you find? So mine was closer to like 50. That's the point where once you
02:05:13.440 get past 50, the benefit of a high-protein diet on mortality seems to outweigh any detriment that you
02:05:20.100 would get from starting earlier. So that's odd to me because whether it's 50 or 60, Matt,
02:05:24.360 it's a benefit on mortality, which is really where more of the argument is. There can't be any benefit
02:05:30.920 on healthspan. From low-protein, you mean? No, from high-protein. Early in life or late? Why? Why
02:05:35.820 can't there be a benefit? Oh, late in life, I'm saying. Why not? Well, I'm saying like if you're
02:05:39.680 protein-restricted late in life... Low-protein has no benefit on healthspan. Yeah, yeah, yeah. So I would agree
02:05:44.900 with you intuitively. I'll exclude special cases. So I'm not talking about people who have renal
02:05:49.800 insufficiency for whom they have to restrict. I agree with you conceptually. The only thing that
02:05:53.780 makes me hesitate a little bit is I've just seen, like I was talking about the mouse rapamycin
02:05:58.200 experiments where everybody who knew anything about muscle said that if you gave a mouse rapamycin
02:06:03.260 throughout life, it was going to get sarcopenia. And that just didn't happen. No, but I'm saying we
02:06:07.240 have clinical data that suggests that when people over the age of 65 are protein deficient versus
02:06:12.780 protein significant, there's a huge difference in muscle mass. Which we know is going to be
02:06:17.780 associated with frailty and poor outcome. I would totally agree with that. I don't know.
02:06:22.660 Do we have controlled studies where people were eating low-protein and doing resistance training
02:06:26.720 late in life? There are nuance here that could complicate things. But I think in general,
02:06:30.260 you're probably right. I think the other area where this gets
02:06:32.200 very complicated is the, I don't want to say by necessity, but just by convention, we use IGF-1
02:06:39.740 as a biomarker for protein intake. It's certainly associated with protein intake, but you want to tell
02:06:45.860 people what IGF-1 is, where it comes from, and what it's a proxy for?
02:06:49.600 So IGF-1 is insulin-like growth factor one. It's a hormone that's in the growth hormone pathway. So
02:06:55.460 you can think of as a growth-promoting hormone. It's part of this central pathway that promotes
02:07:00.660 growth in many, many different tissues. So if you have high growth hormone levels,
02:07:04.780 you'll have high IGF-1 levels and high mTOR. This is a part of the mTOR pathway as well, upstream of mTOR.
02:07:10.260 The reason why people have been really interested in IGF-1 in the field of aging biology, it comes
02:07:17.640 from studies, again, in the very simple laboratory model systems. So the most famous and one of the
02:07:24.280 first genes that was shown to clearly from a mechanistic perspective affect aging is it comes
02:07:29.940 from Cynthia Kenyon and even Tom Johnson a little bit before her, which is the insulin-like receptor
02:07:35.580 in C. elegans called DAF-2. And Cynthia published a classic paper showing that if you make a mutation
02:07:40.700 in DAF-2, it could double the lifespan of worms, and they seem to be healthier about twice as long.
02:07:46.160 And what that mutation does is it turns down signaling through this pathway. Now, a little
02:07:51.920 bit more complicated in worms because it's called the insulin IGF-1-like signaling pathway. So it's not
02:07:57.480 identical. There's one path in worms that kind of takes the place of both IGF-1 signaling and
02:08:02.520 insulin signaling, but you can kind of think of them as equivalent. And then there are a whole
02:08:05.740 bunch of studies in mice for mostly mutations in the growth hormone upstream signaling upstream of
02:08:13.860 IGF-1 that lead to increased lifespan. So there are- So this means GH does not activate the production
02:08:20.520 of more IGF-1. That's right. So you have through a variety of mechanisms- You have high GH, low IGF-1
02:08:25.580 animals. Well, low GH signaling. But they probably are high in IGF-1. Oftentimes it's the receptor that's
02:08:30.600 mutated. That's right. So those animals tend to be very long-lived. They rival caloric restriction
02:08:36.000 in terms of the magnitude of lifespan extension. And there are several different mutations in that
02:08:40.500 pathway. The mutations in IGF-1, I guess I should know the current state of that literature a little
02:08:45.700 bit better. It's complicated. And there have been some controversies in the field about the different
02:08:50.980 mutations that directly affect IGF-1 itself and the effects on lifespan. So I'm not going to wade into
02:08:58.740 that because I think it still hasn't been resolved. But there's no question that mutations that reduce
02:09:04.140 growth hormone signaling in mice extend lifespan. Now, it's important to understand though that with
02:09:11.180 one exception, those studies are all cases where the animals are growth hormone signaling deficient
02:09:17.260 through development. So they are very, very small animals. And then they have constitutively low
02:09:24.400 levels of signaling through that pathway for the rest of their life. There's one study that I think
02:09:29.340 it used a monoclonal antibody to the IGF-1 receptor in mice. This is from Nir Barzilai and Hasi Cohen,
02:09:36.240 where they treated mice with this antibody late in life. And they got, you know, a reasonably sized
02:09:40.640 lifespan extension. I think it was, I don't know, 14, 15% median lifespan.
02:09:45.820 That was an antibody that did not penetrate the CNS, if I recall.
02:09:49.460 I think so.
02:09:49.840 I remember Nir talking about this and saying, you would get all the benefits of IGF in the brain
02:09:54.980 without the benefits of IGF in the, or without the potential harm of IGF in the periphery.
02:09:59.360 Another complication, right? Where the effects of IGF in the brain might be fundamental on,
02:10:03.900 for health span and cognitive function, might be fundamentally different than high IGF-1 in the
02:10:08.420 periphery. So that study, I think, is the best evidence in mice that you can get some benefit
02:10:13.740 specifically from reducing IGF-1 signaling in middle age.
02:10:17.900 And this is such an important question I get asked all the time. I have a lot of patients
02:10:21.420 that are asking to be put on growth hormone. We just don't do it. The reason is, I just am not
02:10:28.060 comfortable with, I don't see enough data in humans to suggest that it's necessarily safe.
02:10:34.700 Conversely, I don't really see evidence to suggest it's not. This is sort of the weird thing with growth
02:10:39.220 hormone. Like if you buy hook, line, and sinker, the argument that more growth hormone equals more IGF
02:10:44.380 equals more mortality. And you look at how much growth hormone is being used. I mean,
02:10:49.460 it is hands down the most abused drug in sports. It's first, second, third. Nobody's even within
02:10:55.740 the zip code. And this is going back 35, maybe 40 years, probably to the early 80s. Where are the
02:11:02.140 bodies? There need to be more bodies. So I'm stuck with, like, I don't see where the bodies are.
02:11:08.420 But at the same time, it's still a bit of a leap for me. And I don't have the luxury of rapamycin data
02:11:14.400 where I can at least point to all of the humans who have taken rapamycin for 23 years. And we know
02:11:21.100 what that looks like. And then even though it's not for gyro protection, and then all of the mechanistic
02:11:26.360 stuff that is consistently pointing the right way. So there's going to be some patient of mine
02:11:30.080 listening to this saying, Peter, you almost talked me into taking growth hormone based on your
02:11:34.240 discussion. And it's, no, I can't. It's funny. I even took it for a week after my shoulder surgery.
02:11:39.940 I had sort of looked at some literature using GH and anabolic steroids to help with recovery.
02:11:45.880 And it could have been true, true, and unrelated. But I felt the worst I've ever felt after a week of
02:11:51.460 growth hormone and nandrolone. And I was like, yeah, I'm done. Now, again, I think it was, I happen to be
02:11:57.580 sick as well. But my blood pressure went up. My blood sugar went up. I felt like crap. I couldn't sleep.
02:12:02.520 Again, a lot of confounding factors, shoulder surgery and a nasty virus. So it could all be
02:12:08.520 irrelevant. So first of all, obviously, I've never given growth hormone to anyone. I've never taken
02:12:12.820 growth hormone. I'm not an expert in the human application of growth hormone. But I've certainly
02:12:17.280 tried to follow that literature. Because based on the mouse studies, you would have predicted,
02:12:22.580 right, that growth hormone therapy should be bad. Should be the most toxic therapy you could give a
02:12:27.000 human. Yeah, certainly should cause increased risk for a bunch of different diseases, including cancer.
02:12:31.240 It's mostly cancer. And my understanding of the literature here is that, like you said, it's not
02:12:36.960 clear that there are significant benefits, particularly for strength. I think there's some
02:12:40.600 evidence that muscle mass may increase, but strength doesn't. But it's also not clear that
02:12:44.440 there's any real detriment, that there's any significant risk, which is a little bit surprising.
02:12:49.120 Yeah, it is surprising. And I do have a couple of patients who have taken it. Usually other doctors
02:12:55.740 were prescribing it or, you know, they came in under the care of somebody else. And they all seem to
02:13:00.700 claim they feel infinitely better on it. There may be something to that. It might be that in 20 years,
02:13:06.660 we have enough data to say, you know what, by the time you're 60, you should just be on a slow amount
02:13:11.960 of growth hormone for all of these reasons. I'd love to see somebody do this study. Because it's a very
02:13:18.840 important question to be asked. And I also think we have enough data to suggest that such a study is not
02:13:24.280 unethical. In other words, we don't have an abundance of data. In fact, we have a paucity of
02:13:29.820 data suggesting it's harm, that it would justify ethically doing a study like this. That's sort of
02:13:35.320 a hope I would have, because I really find this to be one of the most confusing questions in this
02:13:39.880 space. I agree. And again, this is sort of why I personally have settled around the idea for now,
02:13:45.360 at least, that IGF-1 particularly is probably not that informative in people, particularly, you know,
02:13:53.220 once you get past 50 years. 50 years is arbitrary, but that's kind of where I would put the number.
02:13:57.840 Obviously, again, IGF-1 itself is complicated, because you don't really know what that means in
02:14:03.300 terms of IGF-1 signaling and downstream activity. Yeah, important, I guess, for people to understand
02:14:07.820 that. Just like testosterone is mostly bound to sexism binding globulin, there's only a small
02:14:13.640 amount of testosterone that's free. It's the same with IGF-1. It has these IGF-BPs,
02:14:18.380 these are binding proteins that bind most of it. And therefore, total IGF is not really
02:14:25.220 completely informative as to what's happening, even in terms of the quantity that's there for
02:14:29.200 signaling, because it's not the unbound portion of it. So, some people look at things like IGF-2
02:14:35.380 IGF-BP ratio. The bigger that number is, in theory, the more IGF signaling you would have. But,
02:14:41.660 you know, this gets to now when you look at sort of the epidemiologic curves,
02:14:45.420 which on the x-axis would show in, you know, deciles or quartiles or whatever buckets,
02:14:51.720 IGF levels rising. And then on the y-axis would show you mortality. I've never seen one of those
02:14:57.780 curves that just goes up. Sometimes they're U-shaped. Sometimes they're downsloped. Sometimes
02:15:02.660 they're flat. And it depends on the indication. But the story seems much more complicated than IGF is
02:15:09.360 bad. You know, going back to the Dean paper that we were talking about, again, it's an important paper.
02:15:14.240 It's a well-done paper. You really have to recognize that population you're looking in
02:15:20.140 might make a big difference as well. If you're talking about a population of people where 30%
02:15:25.240 of them are obese, some high percentage have metabolic disease or diabetes, having high IGF-1
02:15:31.500 in that context might be very different than somebody who is appropriate rate, exercising,
02:15:39.020 eating a high-protein diet, right? And again, those kinds of things don't typically come out
02:15:42.860 in these epidemiological studies. The other thing I'll say is today, I went and tried to look
02:15:47.380 through the literature and see what other studies have shown that same relationship. And they're all
02:15:52.840 over the place. You can find studies that really don't show, or protein consumption particularly,
02:15:57.040 you can find studies epidemiological that really don't show any downside to eating a high-protein diet
02:16:02.500 in people. It's hard for me to draw too much confidence that high-protein is significantly
02:16:08.980 detrimental when you're younger than 50. And I feel pretty confident that a higher, at least certainly
02:16:16.660 higher than the RDA level of dietary protein intake when you're above 50 is beneficial, particularly if
02:16:24.220 you're exercising. I mean, that's where I would be a little bit concerned. If you've got somebody who's
02:16:29.280 overweight, obese, diabetic... Sedentary.
02:16:33.060 So high-calorie plus high-protein could be problematic.
02:16:36.400 Totally agree. And by the way, I frankly think a lot of the epidemiology is tainted by that.
02:16:42.440 It's high-protein in the context of high-calorie.
02:16:44.860 Exactly. The other thing that I think is also potentially interesting to think about in human
02:16:48.820 are these people who have mutations in the growth hormone pathway. So this is now maybe more akin to
02:16:55.360 these mouse models where they have low-growth hormone signaling from development, even in
02:17:00.040 utero, potentially. They go through their entire lives. A couple of studies. Again, Walter Longo,
02:17:04.160 obviously prolific in this area, had a study in little people of Ecuador, right? There have been
02:17:08.720 several studies, but the most...
02:17:10.360 Leron-dwarf syndrome.
02:17:11.480 Yeah, that's right. The Leron syndrome. Yeah. The most famous study is one that was published
02:17:15.200 in Science where they looked at lifespan and age-related health outcomes in the people with
02:17:22.140 low-growth hormone signaling versus controls in their same environment.
02:17:26.400 Environment. Yeah. It's a really fascinating study. The interesting things are there's no
02:17:30.880 difference in lifespan, but the people with low levels of growth hormone signaling, the reduction in
02:17:36.380 cancer risk is profound. I don't remember the exact numbers, but I think it was zero. There was one
02:17:42.900 person in their cohort who developed a cancer. I don't remember what it was, and she was treated,
02:17:46.760 and then she lived the rest of her life. But none of them died from cancer. And the rate of diabetes
02:17:51.660 was lower in the little people. But Ecuador, at least that part of Ecuador at that time, had a very low
02:17:58.460 diabetes rate to begin with, something 5%. So it's a little bit harder to say. But certainly cancer,
02:18:02.620 dramatic reduction in risk of cancer. So why didn't they live longer? And it's a little bit
02:18:08.340 ambiguous. They don't really say, but you know, they say that there is a higher, much higher rate of
02:18:13.180 alcoholism, liver failure, and accidents. This gets back to the social and psychological consequences
02:18:20.540 in humans that are just different than we have in mice. The growth hormone deficient mice aren't going
02:18:26.540 to be subject, well, they might be probably not subject to the same social pressures that somebody,
02:18:33.040 you know, has very low growth hormone signaling in people is subjected to, which may contribute to
02:18:38.100 other things later on, like alcoholism. So anyways, fascinating though, biology, which is consistent
02:18:43.440 with the idea, I think, that you can impact at least a subset of age-related biology by being
02:18:50.460 constitutively low in growth hormone through your entire life. You know, what would happen if you did
02:18:55.780 that in bursts, you know, like post-developmentally, just after puberty, say from your 20s and 30s,
02:19:01.360 who knows, right? We don't have any, there are no naturally occurring examples of that. I don't,
02:19:05.780 or very few that we could look at and actually evaluate.
02:19:09.480 By the way, do we have examples? Is there enough data to look at people with acromegaly during different
02:19:16.640 periods of their life to see if that's had the exact, do we see a higher incidence of cancer?
02:19:21.240 I don't know the answer to that. Those populations would be relatively small, but yeah, maybe,
02:19:26.280 maybe it's possible.
02:19:27.320 Yeah. It seems like, I imagine somebody's looked at that, the incidence of cancer in people with
02:19:31.440 adult onset acromegaly or something to that effect. The other thing I would say on the IGF thing before
02:19:35.960 we leave that is the interplay with insulin. And so high insulin, high IGF, low insulin, low IGF,
02:19:43.500 low insulin, high IGF. I mean, these are very different physiologic states. It's very difficult
02:19:48.780 to think that we're teasing those out when we look at broad swaths.
02:19:53.500 I think this just comes back to the fact that these, especially these epidemiological studies
02:19:57.360 are a mixture of normal people typically. And so the lifestyles most people are living are what
02:20:05.240 gets weighted in those types of analyses. And that may be very different as we talked about,
02:20:10.420 if you are normal weight, high protein, maybe high calorie, because you're extremely active.
02:20:15.060 Then if you're overweight, sedentary, and eating a calorie diet, I really think that's
02:20:20.400 underappreciated and probably really important. And thinking about the cancer risk, this is going
02:20:25.380 to be some pure speculation on my part. There's no question, I don't think, that high growth hormone
02:20:31.100 signaling and high IGF-1 signaling, everything else being equal in a person leads to a higher risk of
02:20:37.880 developing cancer.
02:20:39.200 You don't?
02:20:39.520 I don't. I think that's true.
02:20:40.860 Oh, you do think that's true. Okay.
02:20:41.940 I believe that that's true. Everything else being equal, of course, everything isn't going
02:20:45.440 to be equal. But if we just look at that one variable signaling through that pathway,
02:20:50.100 higher signaling, higher risk of cancer. So then if it's the case, which we could make an argument
02:20:55.400 that that doesn't seem to be the case, at least in certain populations of people that high growth
02:21:01.180 hormone signaling or treating with growth hormone dramatically increases the cancer incidence.
02:21:05.400 So why is that? Or in people who are...
02:21:06.940 And by the way, we should also differentiate between high causes it versus low removes it.
02:21:12.440 Just because we have a genetic example of where not having it creates a deficiency of cancer.
02:21:20.500 So going from sort of 100 to 30 decreases cancer doesn't mean going from 100 to 30 increases cancer.
02:21:27.680 100 to 130 increases cancer.
02:21:29.680 That's right.
02:21:30.040 I mean, we don't know. It could.
02:21:31.020 The word you use there is interesting because you said removes it. No, this isn't what you meant.
02:21:34.940 But this is, I think, something that is also important to appreciate. So to go from pre-initiation
02:21:40.980 of cancer to cancer to metastasis to, you know, somebody dying from it, there's steps that have
02:21:47.320 to happen there. And there are different defense mechanisms that act at each of those steps.
02:21:52.560 My guess is growth hormone and IGF-1 is primarily acting at the very early steps,
02:21:56.880 where we know that if you promote cell division, that that is a sort of a permissive early
02:22:02.220 environment for mutations to happen and cancers to get a foothold. In most cases, it seems to be
02:22:08.860 the case that those early cancers are detected and wiped out by our immune system. One of the
02:22:15.100 reasons why I think a lot of cancers become more prevalent as we get older is because the function
02:22:21.240 of the immune system to detect and clear those cancers declines. There's obviously other stuff going
02:22:26.000 on accumulation of senescent cells, which contributes to this process. But if you are,
02:22:31.000 say, I shouldn't even say this because I bother people about the biological clocks. Let's just say
02:22:35.180 though, theoretically, you're a 60-year-old person, but biologically, because you are exercising,
02:22:42.340 eating an appropriate diet, biologically, you're 40 years old. At least your immune system is
02:22:47.180 functioning like a 40-year-old. You might have a little bit higher IGF-1. You might have a little bit
02:22:52.020 higher of that early cancer risk, but you have a much lower total risk of developing cancer because
02:22:56.960 your immune system has a much better chance of catching it and getting rid of it. And those
02:23:00.880 are things we don't even think about. Well, Matt, I don't know that we settled anything today.
02:23:05.260 Pretty safe to say. We've probably, for the listener, created more questions than answers.
02:23:09.720 No, I'm sure we've done some good. It's a complicated question. And you know,
02:23:13.300 we actually did not dive into the genetic interaction with caloric restriction. So I mean,
02:23:17.100 I think the take-home there is that even in mice where we can control everything else, if you look
02:23:21.280 across genotypes, you get different results from the same diet and the effect of caloric restriction
02:23:26.760 on lifespan. So maybe we can't answer the big detailed questions. I guess the take-homes I would
02:23:32.880 have are, we've learned a ton from these nutritional studies in laboratory animals about the biological
02:23:38.420 mechanisms. We've learned a lot about which proteins and pathways are important. And that has led us to
02:23:45.280 things like rapamycin, which might be a more effective intervention in humans. So they have
02:23:51.760 value for that. The other take-home that we've talked about is you don't have to worry about
02:23:57.080 every little detail. Most people can get a big chunk of the way there by eating a relatively healthy
02:24:05.100 diet. Don't worry so much about how much protein, how much carbs, how much fat, eat good foods,
02:24:09.960 don't overeat, and be active. Exercise. I do worry a little bit that society does this, but scientists
02:24:16.440 do it sometimes too when we start really getting into the weeds and making recommendations to people
02:24:20.940 that we overthink things a little bit. Give people anxiety about, am I eating a low enough protein diet
02:24:25.720 or am I still in ketosis? I got to do my breath monitor every- Yeah, what should my fasting window
02:24:31.440 be? The questions are out there to what extent do any of these things have big benefits. I think you can
02:24:37.180 get most of the benefits without worrying about a lot of that. Yeah, I agree. Well, Matt, glad we
02:24:42.720 finally got to do one of these in person. Yeah, it's been a pleasure. Maybe the next one should be
02:24:45.240 in person as well. Absolutely. Thank you for listening to this week's episode of The Drive.
02:24:49.780 If you're interested in diving deeper into any topics we discuss, we've created a membership
02:24:54.040 program that allows us to bring you more in-depth exclusive content without relying on paid ads.
02:24:59.580 It's our goal to ensure members get back much more than the price of the subscription.
02:25:04.080 Now to that end, membership benefits include a bunch of things.
02:25:07.180 One, totally kick-ass comprehensive podcast show notes that detail every topic, paper,
02:25:12.540 person, thing we discuss on each episode. The word on the street is nobody's show notes rival these.
02:25:18.480 Monthly AMA episodes or Ask Me Anything episodes, hearing these episodes completely.
02:25:23.600 Access to our private podcast feed that allows you to hear everything without having to listen to
02:25:28.880 spiels like this. The Qualies, which are a super short podcast that we release every Tuesday
02:25:34.200 through Friday, highlighting the best questions, topics, and tactics discussed on previous episodes
02:25:38.940 of The Drive. This is a great way to catch up on previous episodes without having to go back and
02:25:43.980 necessarily listen to everyone. Steep discounts on products that I believe in, but for which I'm not
02:25:49.740 getting paid to endorse. And a whole bunch of other benefits that we continue to trickle in
02:25:54.240 as time goes on. If you want to learn more and access these member-only benefits, you can head
02:25:58.540 over to peteratiamd.com forward slash subscribe. You can find me on Twitter, Instagram, and Facebook
02:26:05.600 all with the ID peteratiamd. You can also leave us a review on Apple Podcasts or whatever podcast
02:26:12.400 player you listen on. This podcast is for general informational purposes only and does not constitute
02:26:17.960 the practice of medicine, nursing, or other professional healthcare services, including the giving of
02:26:24.240 advice. No doctor-patient relationship is formed. The use of this information and the materials linked
02:26:29.820 to this podcast is at the user's own risk. The content on this podcast is not intended to be a
02:26:35.860 substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in
02:26:43.180 obtaining medical advice from any medical condition they have, and they should seek the assistance of
02:26:48.560 their healthcare professionals for any such conditions. Finally, I take conflicts of interest
02:26:54.000 very seriously. For all of my disclosures and the companies I invest in or advise, please visit
02:27:00.000 peteratiamd.com forward slash about where I keep an up-to-date and active list of such companies.
02:27:24.000 Thank you.
02:27:31.000 Thank you.
02:27:35.000 Thank you.